CA2475679A1 - Flow condition sensor for infusion device - Google Patents
Flow condition sensor for infusion device Download PDFInfo
- Publication number
- CA2475679A1 CA2475679A1 CA002475679A CA2475679A CA2475679A1 CA 2475679 A1 CA2475679 A1 CA 2475679A1 CA 002475679 A CA002475679 A CA 002475679A CA 2475679 A CA2475679 A CA 2475679A CA 2475679 A1 CA2475679 A1 CA 2475679A1
- Authority
- CA
- Canada
- Prior art keywords
- sensor
- diaphragm
- flow
- flow path
- chamber
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
- A61M5/14248—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/16804—Flow controllers
- A61M5/16809—Flow controllers by repeated filling and emptying of an intermediate volume
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/16831—Monitoring, detecting, signalling or eliminating infusion flow anomalies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3327—Measuring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3331—Pressure; Flow
- A61M2205/3355—Controlling downstream pump pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/16804—Flow controllers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/16831—Monitoring, detecting, signalling or eliminating infusion flow anomalies
- A61M5/16854—Monitoring, detecting, signalling or eliminating infusion flow anomalies by monitoring line pressure
Abstract
A device (10) for delivering fluid to a patient including an exit port assembly (70) adapted to connect to a transcutaneous patient access tool, a flow path (210) extending from the exit port assembly (70), and a flow condition sensor assembly (200) including a resilient diaphragm (220) having opposing first and second surfaces (222, 224). The first surface (222)of the diaphragm (220) is positioned against the flow path (210), and a chamber wall (226) is positioned adjacent the second surface (224) of the diaphragm (220) and defines a sensor chamber (228) against the second surface of the diaphragm (220). At least one sensor is arranged to provide a threshold signal when the second surface (224) of the diaphragm expands into the chamber (228) in response to at least one predetermined fluid flow condition occurring in the flow path (210).
Description
Flow Condition Sensor for Infusion Device FLOW CONDITION SENSOR ASSEMBLY
FOR INFUSION DEVICE
Cross-Reference to Related Applications (O1) The present application is related to co-pending U.S. patent application serial number 09/943,992, filed on August 31, 2001 (Atty. Docket No. INSL-110), and entitled DEVICES, SYSTEMS AND METHODS FOR PATIENT INFUSION, wluch is assigned to the assignee of the present application and incorporated herein by reference.
Field of the Invention (02) The present invention relates generally to medical devices, systems and methods, and more particularly to small, low cost, portable infusion devices and methods that are useable to achieve precise, sophisticated, and programmable flow patterns for the delivery of therapeutic liquids such as insulin to a mammalian patient. Even more particularly, the present invention is directed to a fluid flow sensor assembly for an infusion device and a method of determining fluid flow in an infusion device.
Background of the Invention (03) Today, there are numerous diseases and other physical ailments that are treated by various medicines including pharmaceuticals, nutritional formulas, biologically derived or active agents, hormonal and gene based material and other substances in both solid or liquid form. In the delivery of these medicines, it is often desirable to bypass the digestive system of a mammalian patient to avoid degradation of the active ingredients caused by the catalytic enzymes in the digestive tract and liver.
Delivery of a medicine other than by way of the intestines is known as parenteral delivery. Parenteral delivery of various drugs in liquid form is often desired to enhance the effect of the substance being delivered, insuring that the unaltered medicine reaches its intended site at a significant concentration. Also,~undesired side effects associated with other routes of delivery, such as systemic toxicity, can potentially be avoided.
FOR INFUSION DEVICE
Cross-Reference to Related Applications (O1) The present application is related to co-pending U.S. patent application serial number 09/943,992, filed on August 31, 2001 (Atty. Docket No. INSL-110), and entitled DEVICES, SYSTEMS AND METHODS FOR PATIENT INFUSION, wluch is assigned to the assignee of the present application and incorporated herein by reference.
Field of the Invention (02) The present invention relates generally to medical devices, systems and methods, and more particularly to small, low cost, portable infusion devices and methods that are useable to achieve precise, sophisticated, and programmable flow patterns for the delivery of therapeutic liquids such as insulin to a mammalian patient. Even more particularly, the present invention is directed to a fluid flow sensor assembly for an infusion device and a method of determining fluid flow in an infusion device.
Background of the Invention (03) Today, there are numerous diseases and other physical ailments that are treated by various medicines including pharmaceuticals, nutritional formulas, biologically derived or active agents, hormonal and gene based material and other substances in both solid or liquid form. In the delivery of these medicines, it is often desirable to bypass the digestive system of a mammalian patient to avoid degradation of the active ingredients caused by the catalytic enzymes in the digestive tract and liver.
Delivery of a medicine other than by way of the intestines is known as parenteral delivery. Parenteral delivery of various drugs in liquid form is often desired to enhance the effect of the substance being delivered, insuring that the unaltered medicine reaches its intended site at a significant concentration. Also,~undesired side effects associated with other routes of delivery, such as systemic toxicity, can potentially be avoided.
(04) Often, a medicine may only be available in a liquid form, or the liquid version may have desirable characteristics that cannot be achieved with solid or pill fornz. Delivery of liquid medicines may best be accomplished by infusing directly into the cardiovascular system via veins or arteries, into the subcutaneous tissue or directly into organs, tumors, cavities, bones or other site specific locations within the body.
(OS) Parenteral delivery of liquid medicines into the body is often accomplished by administering bolus injections using a needle and reservoir, or continuously by gravity driven dispensers or transdermal patch technologies.
Bolus injections often imperfectly match the clinical needs of the patient, and usually require larger individual doses than are desired at the specific time they are given.
Continuous delivery of medicine through gravity feed systems compromise the patient's mobility and lifestyle, and limit the therapy to simplistic flow rates and profiles.
Transdermal patches have special requirements of the medicine being delivered, particularly as it relates to the molecular structure, and similar to gravity feed systems, the control of the drug admiustration is severely limited.
(06) Ambulatory infusion pumps have been developed for delivering liquid medicaments to a patient. These infusion devices have the ability to offer sophisticated fluid delivery profiles accomplishing bolus requirements, continuous infusion and variable flow rate delivery. These infusion capabilities usually result in better efficacy of the drug and therapy and less toxicity to the patient's system. An example of a use of an ambulatory infusion pump is for the delivery of insulin for the treatment of diabetes mellitus. These pumps can deliver insulin on a continuous basal basis as well as a bolus basis as is disclosed in LT.S. Patent 4,498,843 to Schneider et al.
(07) The ambulatory pumps often work with a reservoir to contain the liquid medicine, such as a cartridge, a syringe or an IV bag, and use electro-mechanical pumping or metering technology to deliver the medication to the patient via tubing from the infusion device to a needle that is inserted transcutaneously, or through the skin of the patient. The devices allow control and programming via electromechanical buttons or switches located on the housing of the device, and accessed by the patient or clinician.
The devices include visual feedback via text or graphic screens, such as liquid crystal displays lrnown as LCD's, and may include alert or warning lights and audio or vibration signals and alarms. The device can be worn in a harness or pocket or strapped to the body of the patient.
(08) Currently available ambulatory infusion devices are expensive, difficult to program and prepare for infusion, and tend to be bulky, heavy and very fragile. Filling these devices can be difficult and require the patient to carry both the intended medication as well as filling accessories. The devices require specialized care, maintenance, and cleaning to assure proper functionality and safety for their intended long term use. Due to the high cost of existing devices, healthcare providers limit the patient populations approved to use the devices and therapies for which the devices can be used.
(09) Clearly, therefore, there was a need for a programmable and adjustable infusion system that is precise and reliable and can offer clinicians and patients a small, low cost, light-weight, easy-to-use alternative for parenteral delivery of liquid medicines.
(10) In response, the applicant of the present application provided a small, low cost, light-weight, easy-to-use device for delivering liquid medicines to a patient. The device, which is described in detail in co-pending U.S. application serial No.
09/943,992, filed on August 31, 2001, includes an exit port, a dispenser for causing fluid from a reservoir to flow to the exit port, a local processor programmed to cause a flow of fluid to the exit port based on flow instructions from a separate, remote control device, and a wireless receiver connected to the local processor for receiving the flow instructions. To reduce the size, complexity and costs of the device, the device is provided with a housing that is free of user input components, such as a keypad, for providing flow instructions to the local processor.
(11) Such devices for delivering liquid medicines to a patient, however, are preferably monitored during operation to ensure the maximum benefit to the patient and to ensure the patient's safety. In particular, ensuring the proper and intended flow of fluid from such a device is important. For example, the delivery of the liquid medicine should not be interrupted by a blockage in the flow path or tubing, i.e., occlusion, that delivers the liquid medicine to the patient. An occlusion may interfere with the accurate administration of the liquid medicine to the patient, and should be prevented or detected.
Monitoring a fluid delivery device for occlusions during operation, therefore, is preferred.
(12) What is still desired are new and improved devices for delivering fluid to a patient. Preferably, the fluid delivery devices will be simple in design, and inexpensive and easy to manufacture, in order to further reduce the size, complexity and costs of the devices, such that the devices lend themselves to being small and disposable in nature.
In addition, the fluid delivery device will preferably include a flow condition sensor assembly for monitoring the delivery of fluid to a patient, and for ensuring that unwanted flow conditions such as occlusions or an empty fluid reservoir, are quickly detected.
Summary of the W vention (13) The present invention provides a device for delivering fluid, such as insulin for example, to a patient. The device includes an exit port assembly adapted to connect to a transcutaneous patient access tool, a flow path extending from the exit port assembly, and a flow condition sensor assembly. The sensor assembly includes a resilient diaphragm having opposing first and second surfaces, with the first surface positioned against the flow path, a chamber wall positioned adjacent the second surface of the diaphragm and defining a sensor chamber against the second surface of the diaphragm, and at least one sensor arranged to provide a threshold signal when the second surface of the diaphragm expands into the chamber in response to at least one predetermined fluid flow condition occurnng in the flow path. A sensor assembly constructed in accordance with the present invention, therefore, allows at least one predetermined fluid flow condition, such as an occlusion for example, to be detected within the flow path during operation of the fluid flow device.
(14) According to one aspect of the present invention, the predetermined fluid flow condition is one of an occlusion in the flow path, a low flow of fluid in the flow path, a high flow of fluid in the flow path, and a desired flow of fluid in the flow path.
According to another aspect, the chamber has a predetermined volume. According to a further aspect, the diaphragm comprises a thin, flat piece of flexible and resilient material.
(15) According to an additional aspect of the present invention, the sensor is responsive to one of contact, pressure, light, magnetic strength, strain, and density.
According to one aspect, the sensor includes a switch positioned within the chamber such that the second surface of the diaphragm closes the switch upon expanding into the chamber in response to the predetermined fluid flow condition within the flow path.
According to a further aspect, the sensor includes a circuit having a lead positioned on the second surface of the diaphragm and a lead positioned on the chamber wall such that the leads come together and close the circuit when the second surface of the diaphragm expands into the chamber in response to the predetermined fluid flow condition.
According to another aspect, the circuit includes multiple leads positioned on the chamber wall for determining multiple predetermined fluid flow conditions upon the lead on the diaphragm contacting each of the leads on the chamber wall.
(16) According to still another aspect of the present invention, the flow condition sensor assembly includes an alarm connected to the sensor. According to one aspect, the alarm is adapted to be activated upon the sensor providing the threshold signal.
(17) According to yet another aspect of the present invention, a processor is connected to the sensor of the sensor assembly, an alarm is connected to the processor, and the processor is programmed to activate the alarm upon receiving the threshold signal from the sensor. According to a further aspect, the processor is programmed to activate the alarm upon receiving the threshold signal from the sensor for more than a predetermined period. According to another aspect, the processor is programmed to activate the alarm upon receiving the threshold signal from the sensor for less than a predetermined period.
(18) According to a further aspect of the present invention, a processor is connected to the sensor of the sensor assembly, and the processor is programmed to provide a signal indicative of an undesired flow condition upon receiving the threshold signal from the sensor. According to a further aspect, the processor is programmed to provide a signal indicative of an occluded flow condition upon receiving the threshold signal from the sensor for more than a predetermined period. According to another aspect, the processor is programmed to provide a signal indicative of a low flow condition upon receiving the threshold signal from the sensor for less than a predetermined period.
(19) According to yet another aspect of the present invention, the sensor assembly includes multiple sensor chambers positioned against the second surface of the diaphragm. According to another aspect, the sensor assembly includes at least one of the sensors in each chamber. According to an additional aspect, each of the sensor chambers of the sensor assembly has a predetermined volume. According to a further aspect, the predetermined volumes are unequal.
(20) These aspects of the invention together with additional features and advantages thereof may best be understood by reference to the following detailed descriptions and examples taken in connection with the accompanying illustrated drawings.
Brief Description of the Drawings (21) Fig. 1 is a perspective view of a first exemplary embodiment of a fluid delivery device in accordance with this invention shown secured on a patient, and a remote control device for use with the fluid delivery device (the remote control device being enlarged with respect to the patient and the fluid delivery device for purposes of illustration);
(22) Fig. 2 is a sectional side view of the fluid delivery device of Fig. 1 including an exemplary embodiment of a flow condition sensor assembly constructed in accordance with the present invention;
(23) Fig. 3 is a sectional side view of the flow condition sensor assembly of the fluid delivery device of Fig. 2, illustrating operation of the assembly during a flow condition comprising normal flow;
(24) Fig. 4 is a sectional side views of the flow condition sensor assembly of Figs. 2 and 3, illustrating operation of the assembly during a flow condition comprising an occlusion;
(25) Fig. Sa is a graph of pressure versus time illustrating pulses of fluid flow within a flow path of the fluid delivery device of Figs. 1 and 2;
(26) Fig. Sb is a graph of signal strength versus time, shown in both digital and analog form, from the flow condition sensor assembly of Figs. 2 through 4 correlating to the pulses of fluid flow within the flow path of the device for a flow condition comprising a normal fluid flow;
(27) Fig. Sc is a graph of signal strength versus time, shown in both digital and analog form, from the flow condition sensor assembly of Figs. 2 through 4 correlating to the pulses of fluid flow within the flow path of the device for a flow condition comprising a low fluid flow;
(28) Fig. Sd is a graph of signal strength versus time, shown in both digital and analog form, from the flow condition sensor assembly of Figs. 2 through 4 correlating to the pulses of fluid flow within the flow path of the device for a flow condition comprising an occluded fluid flow;
(29) Figs. 6 and 7 are sectional ends views of another exemplary embodiment of a flow condition sensor assembly constructed in accordance with the present invention, illustrating operation of the assembly during two flow conditions;
(30) Figs. 8, 9 and 10 are sectional side views of an additional exemplary embodiment of a flow condition sensor assembly constructed in accordance with the present invention, illustrating operation of the assembly during three flow conditions;
(31) Figs. 11 and 12 are sectional views of another exemplary embodiment of a flow condition sensor assembly constructed in accordance with the present invention, illustrating operation of the assembly during two flow conditions; and (32) Figs. 13, 14 and 15 are sectional views of a further exemplary embodiment of a flow condition sensor assembly constructed in accordance with the present invention, illustrating operation of the assembly during three flow conditions.
(33) Like reference characters designate identical or corresponding components and units throughout the several views.
Detailed Description of the Preferred Embodiments (34) Referring first to Fig. 2, there is illustrated a fluid delivery device including a flow condition sensor assembly 200 constructed in accordance with the present invention. The flow condition sensor 200 monitors flow conditions within a flow path 210 during operation of the device 10, to ensure that fluid is being delivered as intended. The flow path 210 of the fluid delivery device 10 generally includes a reservoir 30, an exit port assembly 70 adapted to connect to, or include a transcutaneous patient access tool such as a needle (not shown), and a dispenser 40 for causing fluid from the reservoir 30 to flow to the exit port assembly 70.
(35) The types of flow conditions to be monitored by the sensor assembly 200 can include, but are not limited to, an occlusion in the flow path 210, an inadequate flow of fluid in the flow path (due to an empty reservoir for example), and an adequate flow of fluid in the flow path. As discussed below, the sensor assembly provides the benefit, among others, of being volume-based, as opposed to simply being pressure-based for example. A description of the fluid delivery device 10, however, is first provided.
(36) The fluid delivery device 10 of Fig. 2 can be used for the delivery of fluids to a person or animal. The types of liquids that can be delivered by the fluid delivery device 10 include, but are not limited to, insulin, antibiotics, nutritional fluids, total parenteral nutrition or TPN, analgesics, morphine, hormones or hormonal drugs, gene therapy drugs, anticoagulants, analgesics, cardiovascular medications, AZT or chemotherapeutics. The types of medical conditions that the fluid delivery device 10 might be used to treat include, but are not limited to, diabetes, cardiovascular disease, pain, chronic pain, cancer, AIDS, neurological diseases, Alzheimer's Disease, ALS, Hepatitis, Parkinson's Disease or spasticity. In addition, it should be understood that the flow condition sensor assembly 200 according to the present invention can be used with fluid delivery devices other than those used for the delivery of fluids to persons or animals.
(37) The fluid delivery device 10 also includes a processor or electronic microcontroller (hereinafter referred to as the "local" processor) 50 cormected to the dispenser 40. The local processor 50 is programmed to cause a flow of fluid to the exit port assembly 70 based on flow instructions from a separate, remote control device 100, an example of which is shown in Fig. 1. Referring also to Fig. 2, the fluid delivery device 10 further includes a wireless receiver 60 connected to the local processor 50 for receiving the flow instructions from the separate, remote control device 100 and delivering the flow instructions to the local processor. The device 10 also includes a housing 20 containing the exit port assembly 70, the reservoir 30, the dispenser 40, the local processor 50, the wireless receiver 60, and the flow condition sensor assembly 200.
(38) As shown, the housing 20 of the fluid delivery device 10 is free of user input components for providing flow instructions to the local processor 50, such as electromechanical switches or buttons on an outer surface 21 of the housing, or interfaces otherwise accessible to a user to adjust the programmed flow rate through the local processor 50. The lack of user input components allows the size, complexity and costs of the device 10 to be substantially reduced so that the device 10 lends itself to being small and disposable in nature. Examples of such devices are disclosed in co-pending U.S. patent application serial number 09/943,992, filed on August 31, 2001 (Atty.
Docket No. INSL-110), and entitled DEVICES, SYSTEMS AND METHODS FOR
PATIENT INFUSION, which is assigned to the assignee of the present application and has previously been incorporated herein by reference.
(39) In order to program, adjust the programming of, or otherwise communicate user inputs to the local processor 50, the fluid delivery device 10 includes the wireless communication element, or receiver 60 for receiving the user inputs from the separate, remote control device 100 of Fig. 1. Signals can be sent via a communication element (not shown) of the remote control device 100, which can include or be connected to an antenna 130, shown in Fig. 1 as being external to the device 100.
(40) The remote control device 100 has user input components, including an array of electromechanical switches, such as the membrane keypad 120 shown.
The control device 100 also includes user output components, including a visual display, such as a liquid crystal display (LCD) 110. Alternatively, the control device can be provided with a touch screen for both user input and output. Although not shown in Fig.
1, the remote control device 100 has its own processor (hereinafter referred to as the "remote"
processor) connected to the membrane keypad 120 and the LCD 110. The remote processor receives the user inputs from the membrane keypad 120 and provides "flow"
instructions for transmission to the fluid delivery device 10, and provides information to the LCD 110. Since the remote control device 100 also includes a visual display 110, the fluid delivery device 10 can be void of an information screen, further reducing the size, complexity and costs of the device 10.
(41) The communication element 60 of the device 10 preferably receives electronic communication from the remote control device 100 using radio frequency or other wireless communication standards and protocols. In a preferred embodiment, the communication element 60 is a two-way communication element, including a receiver and a transmitter, for allowing the fluid delivery device 10 to send information back to the remote control device 100. In such an embodiment, the remote control device 100 also includes an integral communication element comprising a receiver and a transmitter, for allowing the remote control device 100 to receive the information sent by the fluid delivery device 10.
(42) The local processor 50 of the device 10 contains all the computer programs and electronic circuitry needed to allow a user to program the desired flow patterns aald adjust the program as necessary. Such circuitry can include one or more microprocessors, digital and analog integrated circuits, resistors, capacitors, transistors and other semiconductors and other electronic components known to those skilled in the art. The local processor 50 also includes programming, electronic circuitry and memory to properly activate the dispenser 40 at the needed time intervals.
(43) In the exemplary embodiment of Fig. 2, the device 10 includes a power supply 80, such as a battery or capacitor, for supplying power to the local processor 50.
The power supply 80 is preferably integrated into the fluid delivery device 10, but can be provided as replaceable, e.g., a replaceable battery.
(44) Although not shown, the device 10 can include sensors or transducers such as a reservoir volume transducer or a reservoir pressure transducer, for transmitting information to the local processor 50 to indicate how and when to activate the dispenser 40, or to indicate other parameters determining flow, pump flow path prime condition, blockage in flow path, contact sensors, rotary motion or other motion indicators, as well as conditions such as the reservoir 30 being empty or leaking, or the dispensing of too much or too little fluid from the reservoir, etc.
(45) The volume of the reservoir 30 is chosen to best suit the therapeutic application of the fluid delivery device 10 impacted by such factors as available concentrations of medicinal fluids to be delivered, acceptable times between refills or disposal of the fluid delivery device 10, size constraints and other factors.
The reservoir 30 may be prefilled by the device manufacturer or a cooperating drug manufacturer, or may include external filling means, such as a fill port having needle insertion septum or a Luer connector, for example. In addition, the device 10 can be provided with a removable reservoir.
(46) The exit port assembly 70 can include elements to penetrate the skin of the patient, such that the entire volume of the flow path 210 of the fluid delivery device is predetermined. For example, a needle-connection tubing terminating in a skin penetrating cannula (not shown) can be provided as an integral part of the exit port assembly 70, with the skin penetrating cannula comprising a rigid member, such as a needle. The exit port assembly 70 can further be provided with inj ection means, such as a spring driven mechanism, to assist in penetrating the skin with the skin penetrating cannula. For example, if the cammla is a flexible tube, a rigid penetrator within the lumen of the tube can be driven through the skin by the injection means and then withdrawn, leaving the soft cannula in place in the subcutaneous tissue of the patient or other internal site. The injection means may be integral to the device 10, or removable soon after transcutaneous penetration.
(47) Alternatively, the exit port assembly 70 can be adapted to comiect, with a Luer connector for example, to a separate, standard infusion device that includes a skin penetrating cannula. In any event, the exit port assembly 70 can also be provided with a removable plug (not shown) for preventing leakage during storage and shipment if pre-filled, and during priming if filled by user, and prior to use. It should be understood that, as used herein, the term "flow path" is meant to include all portions of the fluid delivery device 10 that contain therapeutic fluid for delivery to a patient, e.g., all portions between the fill port of the reservoir to the tip of the needle of the exit port assembly.
(48) The device 10 can also be provided with an adhesive layer on the outer surface of the housing 20 for securing the device 10 directly to the skin of a patient, as shown in Fig. 1. Although not shown, the adhesive layer is preferably provided in a continuous ring encircling the exit port assembly 70 in order to provide a protective seal around the penetrated slcin. The housing 20 can be made from flexible material, or can be provided with flexible hinged sections that allow the fluid delivery device 10 to flex during patient movement to prevent detachment and aid in patient comfort.
(49) In the exemplary embodiment of Fig. 2, the device 10 is provided with a pressurized reservoir 30, and the dispenser 40 is adapted to control flow from the reservoir 30. The dispenser 40 does not create a driving or pumping force on the fluid passing therethrough, but rather acts as a metering device, allowing pulses of fluid to pass from the pressurized reservoir 30, through the dispenser 40, to the exit port assembly 70. Examples of such "metering" dispensers are shown in co-pending U.S.
patent application serial no. 09/977,434, filed October 12, 2001 (Atty. Docket No. INSL-116), and entitled LAMINATED PATIENT INFUSION DEVICE, which is assigned to the assignee of the present application and incorporated herein by reference.
It should be understood, however, that "driving or pumping" type dispensers can also be used with a device incorporating a sensor assembly 200 of the present invention. Examples of such "driving or pumping" dispensers are shown in co-pending U.S. patent application serial no. 09/955,623, filed on September 19, 2001 (Atty. Docket No. INSL-117), and entitled PLUNGER FOR PATIENT INFUSION DEVICE, which is assigned to the assignee of the present application and incorporated herein by reference. In any event, the dispenser 40 is controlled by the local processor 50, which includes electronic programming, controls, and circuitry to allow sophisticated fluid delivery programming and control of the dispenser 40.
(50) Referring now to Figs. 3 and 4, an exemplary embodiment of the flow condition sensor assembly 200 of the present invention is shown. The sensor assembly 200 generally includes a resilient diaphragm 220 having opposing first and second surfaces 222, 224, with the first surface 222 positioned against the flow path 210 of the device 10, and a chamber wall 226 positioned adjacent the second surface 224 of the diaphragm. The diaphragm 220 is made from a suitably expandable yet resilient material, such as rubber or a synthetic rubber. The chamber wall 226 is adapted such that an enclosed chamber 228 is defined between the chamber wall 226 and the second surface 224 of the diaphragm 220. Preferably, the chamber 228 is provided with a predetermined volume. Although not shown, the chamber 228 can also be provided with a relief port for allowing air to escape the chamber upon expansion of the diaphragm 220.
(51) The diaphragm 220 and the chamber 228 are arranged and adapted such that during a normal flow condition and between flow pulses, the flow of fluid through the flow path 210 does not cause the diaphragm 220 to expand into the chamber 228, as illustrated in Fig. 3. The diaphragm 220 and the chamber 228 are also arranged and adapted such that during a normal flow condition, the flow of fluid through the flow path 210 causes the diaphragm 220 to expand fully into the chamber 228 for about a predetermined period. During an occluded flow condition (downstream occlusion), the diaphragm 220 expands fully into the chamber, as illustrated in Fig. 4, for more than the predetermined period. During a low flow condition (due to an upstream occlusion, a fluid leak, or an empty reservoir for example), the diaphragm 220 may expand fully into the chamber, but for less than the predetermined period, or may not expand into the chamber.
(52) In any event, the diaphragm 220 and the chamber 228 are arranged and adapted such that the amount of expansion and the duration of the expansion of the diaphragm into the chamber can be used to determine the flow condition within the flow path 210.
(53) The sensor assembly 200 also includes at least one sensor 230 arranged to provide a signal when the second surface 224 of the diaphragm 220 expands into the chamber 228 in response to at least one predetermined fluid flow condition occurring in the flow path 210. For example, the sensor 230 can be arranged to determine when the second surface 224 of the diaphragm 220 expands fully into the chamber 228 and contacts the chamber wall 226, as illustrated in Fig. 4.
(54) The sensor 230 can comprise any device for determining and providing an indication of the position of the diaphragm 220 in the chamber 228. For example, the sensor can comprises one of a contact or pressure switch, a magnetic Hall effect sensor, a strain gage, and a density gage. In the embodiment of Figs. 3 and 4, the sensor comprises an open circuit 230 having two leads 232, 234. The sensor 230 also includes a conductive coating 236 on the second surface 224 of the diaphragm 220. During full expansion of the diaphragm 220 into the chamber 228, the conductive coating eventually contacts both leads 232, 234, and closes the circuit 230.
(55) In the embodiment 200 of the invention illustrated in Figs. 2, the processor 50 of the fluid delivery device 10 also acts as the processor for the sensor assembly 200 and is connected to the open circuit 230. During full expansion of the diaphragm 220 into the chamber 228, the circuit 230 is closed to provide a "signal" to the processor 50.
(56) Alternatively, the sensor assembly 200 can be provided with its own, separate processor programmed to operate in accordance with the present invention. In addition, the sensor 230 can simply be connected to an alarm, such as a light emitting diode or an electronic sound maker, and which is activated upon the circuit of the sensor 230 being closed upon a predetermined flow condition, such as an occlusion. In this manner, a user can simply receive a visual or an audible alarm signal upon full expansion of the diaphragm 220 into the chamber 228 to close the circuit 230.
(57) Figs. Sa through Sd illustrate an exemplary embodiment of a method of determining flow conditions according to the present invention and as carried out by the processor 50. Fig. Sa is a graph of pressure versus time illustrating pulses "p" of fluid flow within the flow path 210 of the fluid delivery device 10 of Figs. 1 and 2 as produced by the dispenser 40 during normal operation. As shown, pulses "p" occur at predetermined intervals "I" and each pulse "p" lasts for a predetermined pulse period "tp". Fig. Sb is a graph of signal strength versus time, shown in both digital form "d" and analog form "a", from the flow condition sensor assembly 200 of Figs. 2 through 4, correlating to the pulses "p" of fluid flow within the flow path 210 of the device 10 for a flow condition comprising a normal fluid flow. As shown, the digital signal "d", which are based on predetermined "threshold" levels of the analog signals "a", each lasts for a predetermined normal period "t"". The processor 50 can be provided with an analog-to-digital converter for converting the analog signals "a" from the sensor 230 to digital signals "d".
(58) Fig. Sc is a graph of signal strength versus time correlating to the pulses of fluid flow within the flow path 210 of the device 10 for a flow condition comprising a low fluid flow. A low flow condition might occur, for example, when the reservoir becomes empty. As shown, each digital signal "d" lasts for a period "t" less than the predetermined normal period "t"". Fig. Sd is a graph of signal strength versus time correlating to the pulses of fluid flow within the flow path 210 of the device 10 for a flow condition comprising an occluded fluid flow. As shown, the digital signals "d" last for a period "t" greater then the predetermined normal period "t"".
(59) The analog signals "a" illustrated in Figs. Sb through Sd are produced upon the second surface 224 of the diaphragm 220 expanding fully into the chamber 228 and closing the sensor circuit 230, as illustrated in Fig. 4. Upon receiving signals "a"
such as those illustrated in Figs. Sc and Sd, the processor 50 is programmed to send an "undesired flow condition" signal to the remote control device 100 to warn a user that the flow delivery device 10 is not producing a desired flow condition.
Although not shown, the remote control device 100 can include an alarm, such as an audible or visual alarm, that the remote processor of the remote control device 100 activates upon receiving the "undesired flow condition" signal from the local processor 50.
In addition, the fluid delivery device 10 can be provided with an alarm, such as a light emitting diode or electronic buzzer, connected to the local processor 50 for activation during an undesired flow condition. In any event, since the delivery device 10 is not producing the desired flow condition, the user may not be receiving the proper amount of medication, or other fluid, and is therefore warned. Because the fluid delivery device 10 of the present invention is preferably disposable and relatively inexpensive, the user can simply dispose of the fluid delivery device 10 with the "undesired flow condition"
and begin using a new fluid delivery device 10.
(60) Because the chamber 228 of the sensor assembly 200 is provided with a predetermined volume, a user is more quickly able to determine the occurrence of an undesired flow condition. Most existing occlusion sensor devices monitor pressure to determine flow conditions. The present invention, in contrast, determines an occlusion condition on a volume "not infused". A low occlusion volume correlates to low volume "not infused" prior to the alarm being activate. A low occlusion volume also corresponds to low volume infused if the occlusion is corrected and proper fluid flow restored. This low volume has the clinical benefit of both early detection (amount of fluid not infused to patient prior to alarm state) as well as a low "bolus"
volume in the cases where the occlusion is removed (such as the case where kinked tubing causes the occlusion and the kink is removed - "dumping" up to that volumetric amount into the patient almost immediately).
(61) The preferred volume of the chamber must take into account the compliance of the entire flow path 210 of system 10. At relative infusion and occlusion pressures, the flow path 210 may expand, thereby artificially adding to the volume of the sensor chamber. Any such artificially expanded volume must be taken into account in monitoring the signals received from the sensor. Preferably, the flow path 210 is designed to have minimal compliance at both normal operating pressures and abnormal operating pressures. If minimal compliance of the flow path is not possible, however, the computer algorithm of the processor can be programmed to take the known compliance of the flow path 210 into account when determining flow conditions based upon signals received from the sensor.
(62) In one possible embodiment of the invention, one of the local processor 50 and the remote processor is programmed to note the time when a "undesired flow condition" signal is received, such that a user knows when an undesired flow condition began.
(63) In another exemplary embodiment, the processor is provided with a software algorithm for avoiding "occlusion detection" during pumping, by instructing the processor to check for occlusion when actual pumping by the dispenser has ceased. The processor can also be programmed to check for proper flow conditions during an initial priming function of the fluid flow device 10. If the processor determines through the sensor assembly that the fluid delivery device is not producing a desired flow condition, the processor is programmed to shut the fluid delivery device down and signal an alarm before attachment of the fluid delivery device to a patient.
(64) Referring back to Figs. 3 and 4, the exemplary embodiment of the sensor assembly is constructed from at least two laminated layers 250, 252, 254 of material in addition to the diaphragm 220. The layers 250, 252, 254 can be made from a suitably strong and rigid material such as plastic or stainless steel, and can be secured together in a suitable manner, such as with adhesives or by welding. The laminated construction provides many benefits including, but not limited to, simplifying the design and manufacturing of the sensor assembly 200, and further reducing the size, complexity and costs of the fluid delivery device 10. The sensor assembly 200 of the present invention, therefore, lends itself to being small and disposable in nature.
(65) In the embodiment of Figs. 3 and 4, the layers of the sensor assembly include a first layer 250 and a second layer 252 received against the first layer. At least one of the second and the first layers 250, 252 includes a surface groove 258 between the layers which forms part of the flow path 210 of the fluid delivery device 10 connected between the dispenser 40 and the exit port assembly 70. The second layer 252 includes an opening 260 in fluid communication with the passageway. The resilient diaphragm 220 is received on the second layer 254 covering the opening 260, and a third layer 256 is received over the diaphragm 220 on the second layer. The third layer 256 forms the chamber wall 226 that defines the chamber 228 over the diaphragm 220 and in alignment with the opening 260 of the second layer 252.
(66) The laminated construction of the sensor assembly 200 allows most manufacturing tolerances of the sensor assembly 200 to be lowered, and the manufacturing process to be simplified, without effecting the performance and reliability of the sensor assembly 200. A relatively high tolerance is required for only the volume of the chamber 228. Other dimensions and properties of the sensor assembly 200 can be relatively relaxed to reduce the costs of the assembly. For example, in the embodiment shown, at least one of the second and the third layers 252, 254 defines a recess 262 receiving the diaphragm 220. The recess 262 has a depth about equal to a thickness of the diaphragm 220 such that the diaphragm 220 is secured in a substantially fluid-tight manner between the second and the third layers 252, 254. However, a length and a width of the recess 262 are greater than a length and a width of the diaphragm 220 in order to decrease the required manufacturing tolerances of the sensor assembly 200. A
resilience of the diaphragm 220 does not require a relatively high tolerance, as long as the resilience of the diaphragm is great enough to force fluid out of the chamber between normal, non-occluded pulses, yet flexible enough to expand into the chamber during an occluded flow.
(67) In alternative embodiments, the diaphragm can be provided as other than a flat layer 220 of resiliently expandable material. The diaphragm can include any structure that provides a fluid-tight barrier between the flow path 210 and the sensor chamber 228, and that moves into the chamber upon an increase in pressure in the flow path. For example, the diaphragm may be provided as a piston biased away from the chamber wall with a spring. Many alternative embodiments of the diaphragm are possible while remaining within the scope of the present invention.
(68) In an alternative embodiment of the sensor assembly of the present invention, the sensor assembly is positioned at the end of a reservoir in a fluid delivery device including a "driving or pumping" type dispenser. As previously discussed, examples of such "driving or pumping" dispensers are shown in co-pending U.S.
patent application serial no. 09/955,623, filed on September 19, 2001 (Atty. Docket No. INSL-117), and entitled PLUNGER FOR PATIENT INFUSION DEVICE. Positioning the sensor assembly at the end of a reservoir opposite the dispenser simplifies the manufacturing process of the sensor assembly and the fluid delivery device and can reduce the number of parts to be assembled.
(69) Figs. 6 and 7 are sectional ends views of another exemplary embodiment of a flow condition sensor assembly 300 constructed in accordance with the present invention, illustrating operation of the assembly during two flow conditions.
Operation of the assembly 300 of Figs. 6 and 7 is similar to operation of the assembly 200 of Figs.
3 and 4. In addition, some elements of the assembly 300 of Figs. 6 and 7 are similar to elements of the assembly 200 of Figs. 3 and 4 such that similar elements have the same reference numeral preceded by a "3". The flow condition sensor assembly 300 of Figs. 6 and 7, however, includes a sensor 330 comprising an optical transmitter 332 and an optical receiver 334 positioned at opposite ends of an optical pathway 336 passing through the sensor chamber 328. The optical transmitter, receiver and pathway 332, 334, 336 are arranged and adapted such that expansion of the diaphragm 320 into the chamber 328 breaks a light beam passing through the pathway 336. When the light beam is broken, the optical receiver 334 provides a signal to the processor and/or alarm that it is connected to, similar to the signal received from the sensor 200 of Figs. 3 and 4.
(70) Figs. 8, 9 and 10 are sectional side views of an additional exemplary embodiment of a flow condition sensor assembly 400 constructed in accordance with the present invention, illustrating operation of the assembly during three flow conditions.
Operation of the assembly 400 is similar to operation of the assembly 200 of Figs. 3 and 4. In addition, elements of the assembly 400 are similar to elements of the assembly 200 of Figs. 3 and 4 such that similar elements have the same reference numeral preceded by a "4". The flow condition sensor assembly 400, however, includes a sensor comprising multiple open circuits 430.
(71) In the embodiment shown, the sensor includes four open circuits 430 and each of the circuits shares a first lead 432 connected to the conductive coating 436 on the second surface 424 of the diaphragm 420. The second leads 434, 438, 440, 442 of each circuit 430 are positioned within the chamber 428 such that, during expansion of the diaphragm 420 into the chamber 428, the conductive coating 436 successively contacts the second leads 434, 438, 440, 442 of the circuits, and successively closes the circuits 430, and thereby provides successive "signals" to the processor and/or alarm connected to the circuits 430. The second leads 434, 438, 440, 442 are positioned within the chamber 428 in a predetermined manner such that the closing of one or more of the circuits 430 for a predetermined period indicates a particular flow condition.
For example, the processor is programmed to determine that an undesired "low" flow condition is occurring if the fluid flow through the flow path causes the diaphragm 420 to expand and contact only one of the second leads 434, as shown in Fig. 9. If the diaphragm 420 expands and contacts two of the second leads 434, 438 as shown in Fig.
10, the processor is programmed to determine that a desired or "normal" flow condition is occurring. If the diaphragm 420 contacts three of the second leads 434, 438, 440, the processor is programmed to determine that an undesired "high" flow condition is occurnng. If the diaphragm 420 expands and contacts all four of the second leads 434, 438, 440, 442, the processor is programmed to determine that an undesired "occlusion"
flow condition is occurring.
(72) In relation to multiple "trigger" points 434, 438, 440, 442, the detection of low flow, normal flow, occluded flow, as described is one use.
Alternatively, each "trigger" point 434, 438, 440, 442 can be adapted to indicate am occlusion condition, but for different occlusion amounts. These points 434, 438, 440, 442 can be set to trigger different types of alarms, or the user or clinician may set one of the triggers 434, 438, 440, 442 to indicate a preferred occlusion volume. For example, a specific drug, such as insulin, may need to trigger at as low an occlusion volume as possible, while a different drug such as an antibiotic or analgesic, may have a larger occlusion volume as more appropriate. The settings could be preprogrammed at manufacturing (multi-application manufactured pump, specifically sold for one application) or can be selected by the user or clinician prior to use.
(73) Figs. 11 and 12 are sectional views of another exemplary embodiment of a flow condition sensor assembly 500 constructed in accordance with the present invention, illustrating operation of the assembly 500 during two flow conditions.
Operation of the assembly 500 is similar to operation of the assembly 200 of Figs. 3 and 4. In addition, elements of the assembly 500 are similar to elements of the assembly 200 of Figs. 3 and 4 such that similar elements have the same reference numeral preceded by a "5". The flow condition sensor assembly 500, however, includes multiple chambers 528, 540, 542 having different predetermined volumes, with a sensor 530 positioned in each chamber.
(74) In the embodiment shown, the sensor 500 includes three chambers 528, 540, 542 and each of the chambers has a sensor comprising an open circuit 530, and all three circuits share a lead 532 connected to the conductive coating 536 on the second surface 524 of the diaphragm 520. The second leads 534 of each circuit are positioned within the chambers 528, 540, 542 such that, during expansion of the diaphragm 520 into the chambers 528, 540, 542, the conductive coating 536 successively contacts the second leads 534 of the circuits 530, and successively closes the circuits 530, and thereby provides successive "signals" to the processor and/or alarm connected to the circuits 530.
The second leads 534 are positioned within the chambers 528, 540, 542 in a predetermined manner, and the chambers are provided with predetermined volumes, such that the closing of one or more of the circuits 530 indicates a particular flow condition.
For example, the processor is programmed to determine that an undesired "low"
flow condition is occun-ing if the fluid flow through the flow path causes the diaphragm 520 to expand only into the first chamber 542 and cause only the first circuit 530 to close.
The processor is also programmed to determine that a desired or "normal" flow condition is occurring if the fluid flow causes the diaphragm 520 to expand into the first chamber 542 and the third chamber 528, as shown in Fig. 12, and cause the first and the third circuits 530 to close. If the diaphragm 520 expands into all three chambers 528, 540, 542 and the three circuits 530 are closed, the processor is programmed to determine that an undesired "occlusion" flow condition is occurring.
(75) Alternatively, the processor can be programmed to determine occlusion, but at different volumes, when each or all of the three circuits 530 are closed. In addition, each chamber can be provided with its own diaphragm, and the diaphragms provided with different expansion properties, such as thickness, material, stiffness, etc.
Alternatively, the single diaphragm 520 can be provided with different expansion properties along its length.
(76) Figs. 13, 14 and 15 are sectional views of a further exemplary embodiment of a flow condition sensor assembly 600 constructed in accordance with the present invention, illustrating operation of the assembly 600 during two flow conditions.
Operation of the assembly 600 is similar to operation of the assembly 200 of Figs. 3 and 4. In addition, elements of the assembly 600 are similar to elements of the assembly 200 of Figs. 3 and 4 such that similar elements have the same reference numeral preceded by a "6". The flow condition sensor assembly 600, however, further includes a second diaphragm 620 positioned against the flow path. The second diaphragm 620 is preferably made of material more rigid than the first diaphragm 220 and is used to dampen movement of the first diaphragm 220 such that the sensor 230 can provide more reliable signals. The second diaphragm 620 also provides pressure relief during an occlusion in the flow path, as illustrated in Figs. 14 and 15, to help prevent a leak from forming in the flow path during the higher occlusion pressure. Preferably, a chamber wall 626 is positioned adjacent the second diaphragm 620 and defines a chamber having a predetermined volume.
(77) In one possible embodiment, the processor 50 of the fluid delivery device is programmed to temporarily increase or cause additional fluid flow within the flow path upon determining that an occlusion condition exist. The temporary additional fluid flow causes a pressure increase in the flow path, which might remove the occlusion. The second diaphragm 620 provides pressure relief in the flow path during the temporary additional fluid flow.
(7~) As illustrated by the above described exemplary embodiments, the present invention generally provides a device for delivering fluid to a patient including an exit port assembly adapted to connect to a transcutaneous patient access tool, a flow path extending from the exit port assembly, and a flow condition sensor assembly including a resilient diaphragm having opposing first and second surfaces. The first surface of the diaphragm is positioned against the flow path, and a chamber wall is positioned adjacent the second surface of the diaphragm and defines a sensor chamber against the second surface of the diaphragm. At least one sensor is arranged to provide a threshold signal when the second surface of the diaphragm expands into the chamber in response to at least one predetermined fluid flow condition occurnng in the flow path. The timing, level and duration of the signals from the sensor are correlated by the local processor to the pumping produced by the dispenser, and used to determine the flow condition.
(79) It should be understood that the embodiments described herein are merely exemplary and that a person skilled in the art may make variations and modifications to the embodiments described without departing from the spirit and scope of the present invention. All such equivalent variations and modifications are intended to be included within the scope of this invention as defined by the appended claims.
(OS) Parenteral delivery of liquid medicines into the body is often accomplished by administering bolus injections using a needle and reservoir, or continuously by gravity driven dispensers or transdermal patch technologies.
Bolus injections often imperfectly match the clinical needs of the patient, and usually require larger individual doses than are desired at the specific time they are given.
Continuous delivery of medicine through gravity feed systems compromise the patient's mobility and lifestyle, and limit the therapy to simplistic flow rates and profiles.
Transdermal patches have special requirements of the medicine being delivered, particularly as it relates to the molecular structure, and similar to gravity feed systems, the control of the drug admiustration is severely limited.
(06) Ambulatory infusion pumps have been developed for delivering liquid medicaments to a patient. These infusion devices have the ability to offer sophisticated fluid delivery profiles accomplishing bolus requirements, continuous infusion and variable flow rate delivery. These infusion capabilities usually result in better efficacy of the drug and therapy and less toxicity to the patient's system. An example of a use of an ambulatory infusion pump is for the delivery of insulin for the treatment of diabetes mellitus. These pumps can deliver insulin on a continuous basal basis as well as a bolus basis as is disclosed in LT.S. Patent 4,498,843 to Schneider et al.
(07) The ambulatory pumps often work with a reservoir to contain the liquid medicine, such as a cartridge, a syringe or an IV bag, and use electro-mechanical pumping or metering technology to deliver the medication to the patient via tubing from the infusion device to a needle that is inserted transcutaneously, or through the skin of the patient. The devices allow control and programming via electromechanical buttons or switches located on the housing of the device, and accessed by the patient or clinician.
The devices include visual feedback via text or graphic screens, such as liquid crystal displays lrnown as LCD's, and may include alert or warning lights and audio or vibration signals and alarms. The device can be worn in a harness or pocket or strapped to the body of the patient.
(08) Currently available ambulatory infusion devices are expensive, difficult to program and prepare for infusion, and tend to be bulky, heavy and very fragile. Filling these devices can be difficult and require the patient to carry both the intended medication as well as filling accessories. The devices require specialized care, maintenance, and cleaning to assure proper functionality and safety for their intended long term use. Due to the high cost of existing devices, healthcare providers limit the patient populations approved to use the devices and therapies for which the devices can be used.
(09) Clearly, therefore, there was a need for a programmable and adjustable infusion system that is precise and reliable and can offer clinicians and patients a small, low cost, light-weight, easy-to-use alternative for parenteral delivery of liquid medicines.
(10) In response, the applicant of the present application provided a small, low cost, light-weight, easy-to-use device for delivering liquid medicines to a patient. The device, which is described in detail in co-pending U.S. application serial No.
09/943,992, filed on August 31, 2001, includes an exit port, a dispenser for causing fluid from a reservoir to flow to the exit port, a local processor programmed to cause a flow of fluid to the exit port based on flow instructions from a separate, remote control device, and a wireless receiver connected to the local processor for receiving the flow instructions. To reduce the size, complexity and costs of the device, the device is provided with a housing that is free of user input components, such as a keypad, for providing flow instructions to the local processor.
(11) Such devices for delivering liquid medicines to a patient, however, are preferably monitored during operation to ensure the maximum benefit to the patient and to ensure the patient's safety. In particular, ensuring the proper and intended flow of fluid from such a device is important. For example, the delivery of the liquid medicine should not be interrupted by a blockage in the flow path or tubing, i.e., occlusion, that delivers the liquid medicine to the patient. An occlusion may interfere with the accurate administration of the liquid medicine to the patient, and should be prevented or detected.
Monitoring a fluid delivery device for occlusions during operation, therefore, is preferred.
(12) What is still desired are new and improved devices for delivering fluid to a patient. Preferably, the fluid delivery devices will be simple in design, and inexpensive and easy to manufacture, in order to further reduce the size, complexity and costs of the devices, such that the devices lend themselves to being small and disposable in nature.
In addition, the fluid delivery device will preferably include a flow condition sensor assembly for monitoring the delivery of fluid to a patient, and for ensuring that unwanted flow conditions such as occlusions or an empty fluid reservoir, are quickly detected.
Summary of the W vention (13) The present invention provides a device for delivering fluid, such as insulin for example, to a patient. The device includes an exit port assembly adapted to connect to a transcutaneous patient access tool, a flow path extending from the exit port assembly, and a flow condition sensor assembly. The sensor assembly includes a resilient diaphragm having opposing first and second surfaces, with the first surface positioned against the flow path, a chamber wall positioned adjacent the second surface of the diaphragm and defining a sensor chamber against the second surface of the diaphragm, and at least one sensor arranged to provide a threshold signal when the second surface of the diaphragm expands into the chamber in response to at least one predetermined fluid flow condition occurnng in the flow path. A sensor assembly constructed in accordance with the present invention, therefore, allows at least one predetermined fluid flow condition, such as an occlusion for example, to be detected within the flow path during operation of the fluid flow device.
(14) According to one aspect of the present invention, the predetermined fluid flow condition is one of an occlusion in the flow path, a low flow of fluid in the flow path, a high flow of fluid in the flow path, and a desired flow of fluid in the flow path.
According to another aspect, the chamber has a predetermined volume. According to a further aspect, the diaphragm comprises a thin, flat piece of flexible and resilient material.
(15) According to an additional aspect of the present invention, the sensor is responsive to one of contact, pressure, light, magnetic strength, strain, and density.
According to one aspect, the sensor includes a switch positioned within the chamber such that the second surface of the diaphragm closes the switch upon expanding into the chamber in response to the predetermined fluid flow condition within the flow path.
According to a further aspect, the sensor includes a circuit having a lead positioned on the second surface of the diaphragm and a lead positioned on the chamber wall such that the leads come together and close the circuit when the second surface of the diaphragm expands into the chamber in response to the predetermined fluid flow condition.
According to another aspect, the circuit includes multiple leads positioned on the chamber wall for determining multiple predetermined fluid flow conditions upon the lead on the diaphragm contacting each of the leads on the chamber wall.
(16) According to still another aspect of the present invention, the flow condition sensor assembly includes an alarm connected to the sensor. According to one aspect, the alarm is adapted to be activated upon the sensor providing the threshold signal.
(17) According to yet another aspect of the present invention, a processor is connected to the sensor of the sensor assembly, an alarm is connected to the processor, and the processor is programmed to activate the alarm upon receiving the threshold signal from the sensor. According to a further aspect, the processor is programmed to activate the alarm upon receiving the threshold signal from the sensor for more than a predetermined period. According to another aspect, the processor is programmed to activate the alarm upon receiving the threshold signal from the sensor for less than a predetermined period.
(18) According to a further aspect of the present invention, a processor is connected to the sensor of the sensor assembly, and the processor is programmed to provide a signal indicative of an undesired flow condition upon receiving the threshold signal from the sensor. According to a further aspect, the processor is programmed to provide a signal indicative of an occluded flow condition upon receiving the threshold signal from the sensor for more than a predetermined period. According to another aspect, the processor is programmed to provide a signal indicative of a low flow condition upon receiving the threshold signal from the sensor for less than a predetermined period.
(19) According to yet another aspect of the present invention, the sensor assembly includes multiple sensor chambers positioned against the second surface of the diaphragm. According to another aspect, the sensor assembly includes at least one of the sensors in each chamber. According to an additional aspect, each of the sensor chambers of the sensor assembly has a predetermined volume. According to a further aspect, the predetermined volumes are unequal.
(20) These aspects of the invention together with additional features and advantages thereof may best be understood by reference to the following detailed descriptions and examples taken in connection with the accompanying illustrated drawings.
Brief Description of the Drawings (21) Fig. 1 is a perspective view of a first exemplary embodiment of a fluid delivery device in accordance with this invention shown secured on a patient, and a remote control device for use with the fluid delivery device (the remote control device being enlarged with respect to the patient and the fluid delivery device for purposes of illustration);
(22) Fig. 2 is a sectional side view of the fluid delivery device of Fig. 1 including an exemplary embodiment of a flow condition sensor assembly constructed in accordance with the present invention;
(23) Fig. 3 is a sectional side view of the flow condition sensor assembly of the fluid delivery device of Fig. 2, illustrating operation of the assembly during a flow condition comprising normal flow;
(24) Fig. 4 is a sectional side views of the flow condition sensor assembly of Figs. 2 and 3, illustrating operation of the assembly during a flow condition comprising an occlusion;
(25) Fig. Sa is a graph of pressure versus time illustrating pulses of fluid flow within a flow path of the fluid delivery device of Figs. 1 and 2;
(26) Fig. Sb is a graph of signal strength versus time, shown in both digital and analog form, from the flow condition sensor assembly of Figs. 2 through 4 correlating to the pulses of fluid flow within the flow path of the device for a flow condition comprising a normal fluid flow;
(27) Fig. Sc is a graph of signal strength versus time, shown in both digital and analog form, from the flow condition sensor assembly of Figs. 2 through 4 correlating to the pulses of fluid flow within the flow path of the device for a flow condition comprising a low fluid flow;
(28) Fig. Sd is a graph of signal strength versus time, shown in both digital and analog form, from the flow condition sensor assembly of Figs. 2 through 4 correlating to the pulses of fluid flow within the flow path of the device for a flow condition comprising an occluded fluid flow;
(29) Figs. 6 and 7 are sectional ends views of another exemplary embodiment of a flow condition sensor assembly constructed in accordance with the present invention, illustrating operation of the assembly during two flow conditions;
(30) Figs. 8, 9 and 10 are sectional side views of an additional exemplary embodiment of a flow condition sensor assembly constructed in accordance with the present invention, illustrating operation of the assembly during three flow conditions;
(31) Figs. 11 and 12 are sectional views of another exemplary embodiment of a flow condition sensor assembly constructed in accordance with the present invention, illustrating operation of the assembly during two flow conditions; and (32) Figs. 13, 14 and 15 are sectional views of a further exemplary embodiment of a flow condition sensor assembly constructed in accordance with the present invention, illustrating operation of the assembly during three flow conditions.
(33) Like reference characters designate identical or corresponding components and units throughout the several views.
Detailed Description of the Preferred Embodiments (34) Referring first to Fig. 2, there is illustrated a fluid delivery device including a flow condition sensor assembly 200 constructed in accordance with the present invention. The flow condition sensor 200 monitors flow conditions within a flow path 210 during operation of the device 10, to ensure that fluid is being delivered as intended. The flow path 210 of the fluid delivery device 10 generally includes a reservoir 30, an exit port assembly 70 adapted to connect to, or include a transcutaneous patient access tool such as a needle (not shown), and a dispenser 40 for causing fluid from the reservoir 30 to flow to the exit port assembly 70.
(35) The types of flow conditions to be monitored by the sensor assembly 200 can include, but are not limited to, an occlusion in the flow path 210, an inadequate flow of fluid in the flow path (due to an empty reservoir for example), and an adequate flow of fluid in the flow path. As discussed below, the sensor assembly provides the benefit, among others, of being volume-based, as opposed to simply being pressure-based for example. A description of the fluid delivery device 10, however, is first provided.
(36) The fluid delivery device 10 of Fig. 2 can be used for the delivery of fluids to a person or animal. The types of liquids that can be delivered by the fluid delivery device 10 include, but are not limited to, insulin, antibiotics, nutritional fluids, total parenteral nutrition or TPN, analgesics, morphine, hormones or hormonal drugs, gene therapy drugs, anticoagulants, analgesics, cardiovascular medications, AZT or chemotherapeutics. The types of medical conditions that the fluid delivery device 10 might be used to treat include, but are not limited to, diabetes, cardiovascular disease, pain, chronic pain, cancer, AIDS, neurological diseases, Alzheimer's Disease, ALS, Hepatitis, Parkinson's Disease or spasticity. In addition, it should be understood that the flow condition sensor assembly 200 according to the present invention can be used with fluid delivery devices other than those used for the delivery of fluids to persons or animals.
(37) The fluid delivery device 10 also includes a processor or electronic microcontroller (hereinafter referred to as the "local" processor) 50 cormected to the dispenser 40. The local processor 50 is programmed to cause a flow of fluid to the exit port assembly 70 based on flow instructions from a separate, remote control device 100, an example of which is shown in Fig. 1. Referring also to Fig. 2, the fluid delivery device 10 further includes a wireless receiver 60 connected to the local processor 50 for receiving the flow instructions from the separate, remote control device 100 and delivering the flow instructions to the local processor. The device 10 also includes a housing 20 containing the exit port assembly 70, the reservoir 30, the dispenser 40, the local processor 50, the wireless receiver 60, and the flow condition sensor assembly 200.
(38) As shown, the housing 20 of the fluid delivery device 10 is free of user input components for providing flow instructions to the local processor 50, such as electromechanical switches or buttons on an outer surface 21 of the housing, or interfaces otherwise accessible to a user to adjust the programmed flow rate through the local processor 50. The lack of user input components allows the size, complexity and costs of the device 10 to be substantially reduced so that the device 10 lends itself to being small and disposable in nature. Examples of such devices are disclosed in co-pending U.S. patent application serial number 09/943,992, filed on August 31, 2001 (Atty.
Docket No. INSL-110), and entitled DEVICES, SYSTEMS AND METHODS FOR
PATIENT INFUSION, which is assigned to the assignee of the present application and has previously been incorporated herein by reference.
(39) In order to program, adjust the programming of, or otherwise communicate user inputs to the local processor 50, the fluid delivery device 10 includes the wireless communication element, or receiver 60 for receiving the user inputs from the separate, remote control device 100 of Fig. 1. Signals can be sent via a communication element (not shown) of the remote control device 100, which can include or be connected to an antenna 130, shown in Fig. 1 as being external to the device 100.
(40) The remote control device 100 has user input components, including an array of electromechanical switches, such as the membrane keypad 120 shown.
The control device 100 also includes user output components, including a visual display, such as a liquid crystal display (LCD) 110. Alternatively, the control device can be provided with a touch screen for both user input and output. Although not shown in Fig.
1, the remote control device 100 has its own processor (hereinafter referred to as the "remote"
processor) connected to the membrane keypad 120 and the LCD 110. The remote processor receives the user inputs from the membrane keypad 120 and provides "flow"
instructions for transmission to the fluid delivery device 10, and provides information to the LCD 110. Since the remote control device 100 also includes a visual display 110, the fluid delivery device 10 can be void of an information screen, further reducing the size, complexity and costs of the device 10.
(41) The communication element 60 of the device 10 preferably receives electronic communication from the remote control device 100 using radio frequency or other wireless communication standards and protocols. In a preferred embodiment, the communication element 60 is a two-way communication element, including a receiver and a transmitter, for allowing the fluid delivery device 10 to send information back to the remote control device 100. In such an embodiment, the remote control device 100 also includes an integral communication element comprising a receiver and a transmitter, for allowing the remote control device 100 to receive the information sent by the fluid delivery device 10.
(42) The local processor 50 of the device 10 contains all the computer programs and electronic circuitry needed to allow a user to program the desired flow patterns aald adjust the program as necessary. Such circuitry can include one or more microprocessors, digital and analog integrated circuits, resistors, capacitors, transistors and other semiconductors and other electronic components known to those skilled in the art. The local processor 50 also includes programming, electronic circuitry and memory to properly activate the dispenser 40 at the needed time intervals.
(43) In the exemplary embodiment of Fig. 2, the device 10 includes a power supply 80, such as a battery or capacitor, for supplying power to the local processor 50.
The power supply 80 is preferably integrated into the fluid delivery device 10, but can be provided as replaceable, e.g., a replaceable battery.
(44) Although not shown, the device 10 can include sensors or transducers such as a reservoir volume transducer or a reservoir pressure transducer, for transmitting information to the local processor 50 to indicate how and when to activate the dispenser 40, or to indicate other parameters determining flow, pump flow path prime condition, blockage in flow path, contact sensors, rotary motion or other motion indicators, as well as conditions such as the reservoir 30 being empty or leaking, or the dispensing of too much or too little fluid from the reservoir, etc.
(45) The volume of the reservoir 30 is chosen to best suit the therapeutic application of the fluid delivery device 10 impacted by such factors as available concentrations of medicinal fluids to be delivered, acceptable times between refills or disposal of the fluid delivery device 10, size constraints and other factors.
The reservoir 30 may be prefilled by the device manufacturer or a cooperating drug manufacturer, or may include external filling means, such as a fill port having needle insertion septum or a Luer connector, for example. In addition, the device 10 can be provided with a removable reservoir.
(46) The exit port assembly 70 can include elements to penetrate the skin of the patient, such that the entire volume of the flow path 210 of the fluid delivery device is predetermined. For example, a needle-connection tubing terminating in a skin penetrating cannula (not shown) can be provided as an integral part of the exit port assembly 70, with the skin penetrating cannula comprising a rigid member, such as a needle. The exit port assembly 70 can further be provided with inj ection means, such as a spring driven mechanism, to assist in penetrating the skin with the skin penetrating cannula. For example, if the cammla is a flexible tube, a rigid penetrator within the lumen of the tube can be driven through the skin by the injection means and then withdrawn, leaving the soft cannula in place in the subcutaneous tissue of the patient or other internal site. The injection means may be integral to the device 10, or removable soon after transcutaneous penetration.
(47) Alternatively, the exit port assembly 70 can be adapted to comiect, with a Luer connector for example, to a separate, standard infusion device that includes a skin penetrating cannula. In any event, the exit port assembly 70 can also be provided with a removable plug (not shown) for preventing leakage during storage and shipment if pre-filled, and during priming if filled by user, and prior to use. It should be understood that, as used herein, the term "flow path" is meant to include all portions of the fluid delivery device 10 that contain therapeutic fluid for delivery to a patient, e.g., all portions between the fill port of the reservoir to the tip of the needle of the exit port assembly.
(48) The device 10 can also be provided with an adhesive layer on the outer surface of the housing 20 for securing the device 10 directly to the skin of a patient, as shown in Fig. 1. Although not shown, the adhesive layer is preferably provided in a continuous ring encircling the exit port assembly 70 in order to provide a protective seal around the penetrated slcin. The housing 20 can be made from flexible material, or can be provided with flexible hinged sections that allow the fluid delivery device 10 to flex during patient movement to prevent detachment and aid in patient comfort.
(49) In the exemplary embodiment of Fig. 2, the device 10 is provided with a pressurized reservoir 30, and the dispenser 40 is adapted to control flow from the reservoir 30. The dispenser 40 does not create a driving or pumping force on the fluid passing therethrough, but rather acts as a metering device, allowing pulses of fluid to pass from the pressurized reservoir 30, through the dispenser 40, to the exit port assembly 70. Examples of such "metering" dispensers are shown in co-pending U.S.
patent application serial no. 09/977,434, filed October 12, 2001 (Atty. Docket No. INSL-116), and entitled LAMINATED PATIENT INFUSION DEVICE, which is assigned to the assignee of the present application and incorporated herein by reference.
It should be understood, however, that "driving or pumping" type dispensers can also be used with a device incorporating a sensor assembly 200 of the present invention. Examples of such "driving or pumping" dispensers are shown in co-pending U.S. patent application serial no. 09/955,623, filed on September 19, 2001 (Atty. Docket No. INSL-117), and entitled PLUNGER FOR PATIENT INFUSION DEVICE, which is assigned to the assignee of the present application and incorporated herein by reference. In any event, the dispenser 40 is controlled by the local processor 50, which includes electronic programming, controls, and circuitry to allow sophisticated fluid delivery programming and control of the dispenser 40.
(50) Referring now to Figs. 3 and 4, an exemplary embodiment of the flow condition sensor assembly 200 of the present invention is shown. The sensor assembly 200 generally includes a resilient diaphragm 220 having opposing first and second surfaces 222, 224, with the first surface 222 positioned against the flow path 210 of the device 10, and a chamber wall 226 positioned adjacent the second surface 224 of the diaphragm. The diaphragm 220 is made from a suitably expandable yet resilient material, such as rubber or a synthetic rubber. The chamber wall 226 is adapted such that an enclosed chamber 228 is defined between the chamber wall 226 and the second surface 224 of the diaphragm 220. Preferably, the chamber 228 is provided with a predetermined volume. Although not shown, the chamber 228 can also be provided with a relief port for allowing air to escape the chamber upon expansion of the diaphragm 220.
(51) The diaphragm 220 and the chamber 228 are arranged and adapted such that during a normal flow condition and between flow pulses, the flow of fluid through the flow path 210 does not cause the diaphragm 220 to expand into the chamber 228, as illustrated in Fig. 3. The diaphragm 220 and the chamber 228 are also arranged and adapted such that during a normal flow condition, the flow of fluid through the flow path 210 causes the diaphragm 220 to expand fully into the chamber 228 for about a predetermined period. During an occluded flow condition (downstream occlusion), the diaphragm 220 expands fully into the chamber, as illustrated in Fig. 4, for more than the predetermined period. During a low flow condition (due to an upstream occlusion, a fluid leak, or an empty reservoir for example), the diaphragm 220 may expand fully into the chamber, but for less than the predetermined period, or may not expand into the chamber.
(52) In any event, the diaphragm 220 and the chamber 228 are arranged and adapted such that the amount of expansion and the duration of the expansion of the diaphragm into the chamber can be used to determine the flow condition within the flow path 210.
(53) The sensor assembly 200 also includes at least one sensor 230 arranged to provide a signal when the second surface 224 of the diaphragm 220 expands into the chamber 228 in response to at least one predetermined fluid flow condition occurring in the flow path 210. For example, the sensor 230 can be arranged to determine when the second surface 224 of the diaphragm 220 expands fully into the chamber 228 and contacts the chamber wall 226, as illustrated in Fig. 4.
(54) The sensor 230 can comprise any device for determining and providing an indication of the position of the diaphragm 220 in the chamber 228. For example, the sensor can comprises one of a contact or pressure switch, a magnetic Hall effect sensor, a strain gage, and a density gage. In the embodiment of Figs. 3 and 4, the sensor comprises an open circuit 230 having two leads 232, 234. The sensor 230 also includes a conductive coating 236 on the second surface 224 of the diaphragm 220. During full expansion of the diaphragm 220 into the chamber 228, the conductive coating eventually contacts both leads 232, 234, and closes the circuit 230.
(55) In the embodiment 200 of the invention illustrated in Figs. 2, the processor 50 of the fluid delivery device 10 also acts as the processor for the sensor assembly 200 and is connected to the open circuit 230. During full expansion of the diaphragm 220 into the chamber 228, the circuit 230 is closed to provide a "signal" to the processor 50.
(56) Alternatively, the sensor assembly 200 can be provided with its own, separate processor programmed to operate in accordance with the present invention. In addition, the sensor 230 can simply be connected to an alarm, such as a light emitting diode or an electronic sound maker, and which is activated upon the circuit of the sensor 230 being closed upon a predetermined flow condition, such as an occlusion. In this manner, a user can simply receive a visual or an audible alarm signal upon full expansion of the diaphragm 220 into the chamber 228 to close the circuit 230.
(57) Figs. Sa through Sd illustrate an exemplary embodiment of a method of determining flow conditions according to the present invention and as carried out by the processor 50. Fig. Sa is a graph of pressure versus time illustrating pulses "p" of fluid flow within the flow path 210 of the fluid delivery device 10 of Figs. 1 and 2 as produced by the dispenser 40 during normal operation. As shown, pulses "p" occur at predetermined intervals "I" and each pulse "p" lasts for a predetermined pulse period "tp". Fig. Sb is a graph of signal strength versus time, shown in both digital form "d" and analog form "a", from the flow condition sensor assembly 200 of Figs. 2 through 4, correlating to the pulses "p" of fluid flow within the flow path 210 of the device 10 for a flow condition comprising a normal fluid flow. As shown, the digital signal "d", which are based on predetermined "threshold" levels of the analog signals "a", each lasts for a predetermined normal period "t"". The processor 50 can be provided with an analog-to-digital converter for converting the analog signals "a" from the sensor 230 to digital signals "d".
(58) Fig. Sc is a graph of signal strength versus time correlating to the pulses of fluid flow within the flow path 210 of the device 10 for a flow condition comprising a low fluid flow. A low flow condition might occur, for example, when the reservoir becomes empty. As shown, each digital signal "d" lasts for a period "t" less than the predetermined normal period "t"". Fig. Sd is a graph of signal strength versus time correlating to the pulses of fluid flow within the flow path 210 of the device 10 for a flow condition comprising an occluded fluid flow. As shown, the digital signals "d" last for a period "t" greater then the predetermined normal period "t"".
(59) The analog signals "a" illustrated in Figs. Sb through Sd are produced upon the second surface 224 of the diaphragm 220 expanding fully into the chamber 228 and closing the sensor circuit 230, as illustrated in Fig. 4. Upon receiving signals "a"
such as those illustrated in Figs. Sc and Sd, the processor 50 is programmed to send an "undesired flow condition" signal to the remote control device 100 to warn a user that the flow delivery device 10 is not producing a desired flow condition.
Although not shown, the remote control device 100 can include an alarm, such as an audible or visual alarm, that the remote processor of the remote control device 100 activates upon receiving the "undesired flow condition" signal from the local processor 50.
In addition, the fluid delivery device 10 can be provided with an alarm, such as a light emitting diode or electronic buzzer, connected to the local processor 50 for activation during an undesired flow condition. In any event, since the delivery device 10 is not producing the desired flow condition, the user may not be receiving the proper amount of medication, or other fluid, and is therefore warned. Because the fluid delivery device 10 of the present invention is preferably disposable and relatively inexpensive, the user can simply dispose of the fluid delivery device 10 with the "undesired flow condition"
and begin using a new fluid delivery device 10.
(60) Because the chamber 228 of the sensor assembly 200 is provided with a predetermined volume, a user is more quickly able to determine the occurrence of an undesired flow condition. Most existing occlusion sensor devices monitor pressure to determine flow conditions. The present invention, in contrast, determines an occlusion condition on a volume "not infused". A low occlusion volume correlates to low volume "not infused" prior to the alarm being activate. A low occlusion volume also corresponds to low volume infused if the occlusion is corrected and proper fluid flow restored. This low volume has the clinical benefit of both early detection (amount of fluid not infused to patient prior to alarm state) as well as a low "bolus"
volume in the cases where the occlusion is removed (such as the case where kinked tubing causes the occlusion and the kink is removed - "dumping" up to that volumetric amount into the patient almost immediately).
(61) The preferred volume of the chamber must take into account the compliance of the entire flow path 210 of system 10. At relative infusion and occlusion pressures, the flow path 210 may expand, thereby artificially adding to the volume of the sensor chamber. Any such artificially expanded volume must be taken into account in monitoring the signals received from the sensor. Preferably, the flow path 210 is designed to have minimal compliance at both normal operating pressures and abnormal operating pressures. If minimal compliance of the flow path is not possible, however, the computer algorithm of the processor can be programmed to take the known compliance of the flow path 210 into account when determining flow conditions based upon signals received from the sensor.
(62) In one possible embodiment of the invention, one of the local processor 50 and the remote processor is programmed to note the time when a "undesired flow condition" signal is received, such that a user knows when an undesired flow condition began.
(63) In another exemplary embodiment, the processor is provided with a software algorithm for avoiding "occlusion detection" during pumping, by instructing the processor to check for occlusion when actual pumping by the dispenser has ceased. The processor can also be programmed to check for proper flow conditions during an initial priming function of the fluid flow device 10. If the processor determines through the sensor assembly that the fluid delivery device is not producing a desired flow condition, the processor is programmed to shut the fluid delivery device down and signal an alarm before attachment of the fluid delivery device to a patient.
(64) Referring back to Figs. 3 and 4, the exemplary embodiment of the sensor assembly is constructed from at least two laminated layers 250, 252, 254 of material in addition to the diaphragm 220. The layers 250, 252, 254 can be made from a suitably strong and rigid material such as plastic or stainless steel, and can be secured together in a suitable manner, such as with adhesives or by welding. The laminated construction provides many benefits including, but not limited to, simplifying the design and manufacturing of the sensor assembly 200, and further reducing the size, complexity and costs of the fluid delivery device 10. The sensor assembly 200 of the present invention, therefore, lends itself to being small and disposable in nature.
(65) In the embodiment of Figs. 3 and 4, the layers of the sensor assembly include a first layer 250 and a second layer 252 received against the first layer. At least one of the second and the first layers 250, 252 includes a surface groove 258 between the layers which forms part of the flow path 210 of the fluid delivery device 10 connected between the dispenser 40 and the exit port assembly 70. The second layer 252 includes an opening 260 in fluid communication with the passageway. The resilient diaphragm 220 is received on the second layer 254 covering the opening 260, and a third layer 256 is received over the diaphragm 220 on the second layer. The third layer 256 forms the chamber wall 226 that defines the chamber 228 over the diaphragm 220 and in alignment with the opening 260 of the second layer 252.
(66) The laminated construction of the sensor assembly 200 allows most manufacturing tolerances of the sensor assembly 200 to be lowered, and the manufacturing process to be simplified, without effecting the performance and reliability of the sensor assembly 200. A relatively high tolerance is required for only the volume of the chamber 228. Other dimensions and properties of the sensor assembly 200 can be relatively relaxed to reduce the costs of the assembly. For example, in the embodiment shown, at least one of the second and the third layers 252, 254 defines a recess 262 receiving the diaphragm 220. The recess 262 has a depth about equal to a thickness of the diaphragm 220 such that the diaphragm 220 is secured in a substantially fluid-tight manner between the second and the third layers 252, 254. However, a length and a width of the recess 262 are greater than a length and a width of the diaphragm 220 in order to decrease the required manufacturing tolerances of the sensor assembly 200. A
resilience of the diaphragm 220 does not require a relatively high tolerance, as long as the resilience of the diaphragm is great enough to force fluid out of the chamber between normal, non-occluded pulses, yet flexible enough to expand into the chamber during an occluded flow.
(67) In alternative embodiments, the diaphragm can be provided as other than a flat layer 220 of resiliently expandable material. The diaphragm can include any structure that provides a fluid-tight barrier between the flow path 210 and the sensor chamber 228, and that moves into the chamber upon an increase in pressure in the flow path. For example, the diaphragm may be provided as a piston biased away from the chamber wall with a spring. Many alternative embodiments of the diaphragm are possible while remaining within the scope of the present invention.
(68) In an alternative embodiment of the sensor assembly of the present invention, the sensor assembly is positioned at the end of a reservoir in a fluid delivery device including a "driving or pumping" type dispenser. As previously discussed, examples of such "driving or pumping" dispensers are shown in co-pending U.S.
patent application serial no. 09/955,623, filed on September 19, 2001 (Atty. Docket No. INSL-117), and entitled PLUNGER FOR PATIENT INFUSION DEVICE. Positioning the sensor assembly at the end of a reservoir opposite the dispenser simplifies the manufacturing process of the sensor assembly and the fluid delivery device and can reduce the number of parts to be assembled.
(69) Figs. 6 and 7 are sectional ends views of another exemplary embodiment of a flow condition sensor assembly 300 constructed in accordance with the present invention, illustrating operation of the assembly during two flow conditions.
Operation of the assembly 300 of Figs. 6 and 7 is similar to operation of the assembly 200 of Figs.
3 and 4. In addition, some elements of the assembly 300 of Figs. 6 and 7 are similar to elements of the assembly 200 of Figs. 3 and 4 such that similar elements have the same reference numeral preceded by a "3". The flow condition sensor assembly 300 of Figs. 6 and 7, however, includes a sensor 330 comprising an optical transmitter 332 and an optical receiver 334 positioned at opposite ends of an optical pathway 336 passing through the sensor chamber 328. The optical transmitter, receiver and pathway 332, 334, 336 are arranged and adapted such that expansion of the diaphragm 320 into the chamber 328 breaks a light beam passing through the pathway 336. When the light beam is broken, the optical receiver 334 provides a signal to the processor and/or alarm that it is connected to, similar to the signal received from the sensor 200 of Figs. 3 and 4.
(70) Figs. 8, 9 and 10 are sectional side views of an additional exemplary embodiment of a flow condition sensor assembly 400 constructed in accordance with the present invention, illustrating operation of the assembly during three flow conditions.
Operation of the assembly 400 is similar to operation of the assembly 200 of Figs. 3 and 4. In addition, elements of the assembly 400 are similar to elements of the assembly 200 of Figs. 3 and 4 such that similar elements have the same reference numeral preceded by a "4". The flow condition sensor assembly 400, however, includes a sensor comprising multiple open circuits 430.
(71) In the embodiment shown, the sensor includes four open circuits 430 and each of the circuits shares a first lead 432 connected to the conductive coating 436 on the second surface 424 of the diaphragm 420. The second leads 434, 438, 440, 442 of each circuit 430 are positioned within the chamber 428 such that, during expansion of the diaphragm 420 into the chamber 428, the conductive coating 436 successively contacts the second leads 434, 438, 440, 442 of the circuits, and successively closes the circuits 430, and thereby provides successive "signals" to the processor and/or alarm connected to the circuits 430. The second leads 434, 438, 440, 442 are positioned within the chamber 428 in a predetermined manner such that the closing of one or more of the circuits 430 for a predetermined period indicates a particular flow condition.
For example, the processor is programmed to determine that an undesired "low" flow condition is occurring if the fluid flow through the flow path causes the diaphragm 420 to expand and contact only one of the second leads 434, as shown in Fig. 9. If the diaphragm 420 expands and contacts two of the second leads 434, 438 as shown in Fig.
10, the processor is programmed to determine that a desired or "normal" flow condition is occurring. If the diaphragm 420 contacts three of the second leads 434, 438, 440, the processor is programmed to determine that an undesired "high" flow condition is occurnng. If the diaphragm 420 expands and contacts all four of the second leads 434, 438, 440, 442, the processor is programmed to determine that an undesired "occlusion"
flow condition is occurring.
(72) In relation to multiple "trigger" points 434, 438, 440, 442, the detection of low flow, normal flow, occluded flow, as described is one use.
Alternatively, each "trigger" point 434, 438, 440, 442 can be adapted to indicate am occlusion condition, but for different occlusion amounts. These points 434, 438, 440, 442 can be set to trigger different types of alarms, or the user or clinician may set one of the triggers 434, 438, 440, 442 to indicate a preferred occlusion volume. For example, a specific drug, such as insulin, may need to trigger at as low an occlusion volume as possible, while a different drug such as an antibiotic or analgesic, may have a larger occlusion volume as more appropriate. The settings could be preprogrammed at manufacturing (multi-application manufactured pump, specifically sold for one application) or can be selected by the user or clinician prior to use.
(73) Figs. 11 and 12 are sectional views of another exemplary embodiment of a flow condition sensor assembly 500 constructed in accordance with the present invention, illustrating operation of the assembly 500 during two flow conditions.
Operation of the assembly 500 is similar to operation of the assembly 200 of Figs. 3 and 4. In addition, elements of the assembly 500 are similar to elements of the assembly 200 of Figs. 3 and 4 such that similar elements have the same reference numeral preceded by a "5". The flow condition sensor assembly 500, however, includes multiple chambers 528, 540, 542 having different predetermined volumes, with a sensor 530 positioned in each chamber.
(74) In the embodiment shown, the sensor 500 includes three chambers 528, 540, 542 and each of the chambers has a sensor comprising an open circuit 530, and all three circuits share a lead 532 connected to the conductive coating 536 on the second surface 524 of the diaphragm 520. The second leads 534 of each circuit are positioned within the chambers 528, 540, 542 such that, during expansion of the diaphragm 520 into the chambers 528, 540, 542, the conductive coating 536 successively contacts the second leads 534 of the circuits 530, and successively closes the circuits 530, and thereby provides successive "signals" to the processor and/or alarm connected to the circuits 530.
The second leads 534 are positioned within the chambers 528, 540, 542 in a predetermined manner, and the chambers are provided with predetermined volumes, such that the closing of one or more of the circuits 530 indicates a particular flow condition.
For example, the processor is programmed to determine that an undesired "low"
flow condition is occun-ing if the fluid flow through the flow path causes the diaphragm 520 to expand only into the first chamber 542 and cause only the first circuit 530 to close.
The processor is also programmed to determine that a desired or "normal" flow condition is occurring if the fluid flow causes the diaphragm 520 to expand into the first chamber 542 and the third chamber 528, as shown in Fig. 12, and cause the first and the third circuits 530 to close. If the diaphragm 520 expands into all three chambers 528, 540, 542 and the three circuits 530 are closed, the processor is programmed to determine that an undesired "occlusion" flow condition is occurring.
(75) Alternatively, the processor can be programmed to determine occlusion, but at different volumes, when each or all of the three circuits 530 are closed. In addition, each chamber can be provided with its own diaphragm, and the diaphragms provided with different expansion properties, such as thickness, material, stiffness, etc.
Alternatively, the single diaphragm 520 can be provided with different expansion properties along its length.
(76) Figs. 13, 14 and 15 are sectional views of a further exemplary embodiment of a flow condition sensor assembly 600 constructed in accordance with the present invention, illustrating operation of the assembly 600 during two flow conditions.
Operation of the assembly 600 is similar to operation of the assembly 200 of Figs. 3 and 4. In addition, elements of the assembly 600 are similar to elements of the assembly 200 of Figs. 3 and 4 such that similar elements have the same reference numeral preceded by a "6". The flow condition sensor assembly 600, however, further includes a second diaphragm 620 positioned against the flow path. The second diaphragm 620 is preferably made of material more rigid than the first diaphragm 220 and is used to dampen movement of the first diaphragm 220 such that the sensor 230 can provide more reliable signals. The second diaphragm 620 also provides pressure relief during an occlusion in the flow path, as illustrated in Figs. 14 and 15, to help prevent a leak from forming in the flow path during the higher occlusion pressure. Preferably, a chamber wall 626 is positioned adjacent the second diaphragm 620 and defines a chamber having a predetermined volume.
(77) In one possible embodiment, the processor 50 of the fluid delivery device is programmed to temporarily increase or cause additional fluid flow within the flow path upon determining that an occlusion condition exist. The temporary additional fluid flow causes a pressure increase in the flow path, which might remove the occlusion. The second diaphragm 620 provides pressure relief in the flow path during the temporary additional fluid flow.
(7~) As illustrated by the above described exemplary embodiments, the present invention generally provides a device for delivering fluid to a patient including an exit port assembly adapted to connect to a transcutaneous patient access tool, a flow path extending from the exit port assembly, and a flow condition sensor assembly including a resilient diaphragm having opposing first and second surfaces. The first surface of the diaphragm is positioned against the flow path, and a chamber wall is positioned adjacent the second surface of the diaphragm and defines a sensor chamber against the second surface of the diaphragm. At least one sensor is arranged to provide a threshold signal when the second surface of the diaphragm expands into the chamber in response to at least one predetermined fluid flow condition occurnng in the flow path. The timing, level and duration of the signals from the sensor are correlated by the local processor to the pumping produced by the dispenser, and used to determine the flow condition.
(79) It should be understood that the embodiments described herein are merely exemplary and that a person skilled in the art may make variations and modifications to the embodiments described without departing from the spirit and scope of the present invention. All such equivalent variations and modifications are intended to be included within the scope of this invention as defined by the appended claims.
Claims (97)
1. A device for delivering fluid to a patient, comprising:
A) an exit port assembly adapted to connect to a transcutaneous patient access tool;
B) a flow path extending from the exit port assembly; and C) a flow condition sensor assembly including, a resilient diaphragm having opposing first and second surfaces, with the first surface positioned against the flow path, a chamber wall positioned adjacent the second surface of the diaphragm and defining a sensor chamber adjacent the second surface of the diaphragm, and at least one sensor arranged to provide a threshold signal when the second surface of the diaphragm expands into the chamber in response to at least one predetermined fluid flow condition occurring in the flow path.
A) an exit port assembly adapted to connect to a transcutaneous patient access tool;
B) a flow path extending from the exit port assembly; and C) a flow condition sensor assembly including, a resilient diaphragm having opposing first and second surfaces, with the first surface positioned against the flow path, a chamber wall positioned adjacent the second surface of the diaphragm and defining a sensor chamber adjacent the second surface of the diaphragm, and at least one sensor arranged to provide a threshold signal when the second surface of the diaphragm expands into the chamber in response to at least one predetermined fluid flow condition occurring in the flow path.
2. A device according to Claim 1, wherein the predetermined fluid flow condition comprises one of an occlusion in the flow path, an inadequate flow of fluid in the flow path, and an adequate flow of fluid in the flow path.
3. A device according to Claim 1, wherein the flow path includes a reservoir and the flow condition sensor assembly is positioned at an end of the reservoir.
4. A device according to Claim 1, wherein the flow path includes a reservoir and a passageway providing fluid communication between the reservoir and the exit port assembly, and the flow condition sensor assembly is positioned against the passageway.
5. A device according to Claim 1, wherein the sensor comprises a switch positioned within the chamber such that the second surface of the diaphragm closes the switch upon expanding into the chamber in response to the predetermined fluid flow condition within the flow path.
6. A device according to Claim 1, wherein the sensor is responsive to one of contact, pressure, light, magnetism, strain, and density.
7. A device according to Claim 1, wherein the sensor is positioned on a portion of the chamber wall furthest from the flow path and the enclosed chamber has a predetermined volume.
8. A device according to Claim 1, wherein the sensor comprises a circuit having a lead positioned on the second surface of the diaphragm and a lead positioned on the chamber wall such that the leads come together and close the circuit when the second surface of the diaphragm expands into the chamber in response to the predetermined fluid flow condition.
9. A device according to Claim 1, wherein the sensor comprises a circuit having leads positioned on the chamber wall and a conductive layer positioned on the second surface of the diaphragm such that the conductive layer contacts the leads to close the circuit when the second surface of the diaphragm expands into the chamber in response to the predetermined fluid flow condition.
10. A device according to Claim 1, wherein the flow condition sensor assembly further comprises at least two laminated layers and the diaphragm is positioned between two of the layers.
11. A device according to Claim 10, wherein the at least two laminated layers comprise:
a first layer;
a second layer received against the first layer, the second and the first layers including at least one groove defining a passageway of the flow path, the second layer including an opening in fluid communication with the passageway, and wherein the resilient diaphragm is received on the second layer covering the opening; and a third layer received over the diaphragm on the second layer, the third layer including the chamber wall defining the chamber over the diaphragm and in alignment with the opening of the second layer.
a first layer;
a second layer received against the first layer, the second and the first layers including at least one groove defining a passageway of the flow path, the second layer including an opening in fluid communication with the passageway, and wherein the resilient diaphragm is received on the second layer covering the opening; and a third layer received over the diaphragm on the second layer, the third layer including the chamber wall defining the chamber over the diaphragm and in alignment with the opening of the second layer.
12. A device according to Claim 11, wherein one of the second and the third layers defines a recess receiving the diaphragm, and wherein the recess has a depth about equal to a thickness of the diaphragm such that the diaphragm is secured in a substantially fluid-tight manner between the second and the third layers.
13. A device according to Claim 12, wherein a length and a width of the recess are greater than a length and a width of the diaphragm.
14. A device according to Claim 1, wherein the diaphragm comprises a thin, flat piece of flexible and resilient material.
15. A device according to Claim 1, wherein the sensor chamber has a predetermined volume.
16. A device according to Claim 1, wherein the flow condition sensor assembly includes an alarm connected to the sensor.
17. A device according to Claim 16, wherein the alarm comprises an audible alarm.
18. A device according to Claim 16, wherein the alarm comprises a visual alarm.
19. A device according to Claim 1, further comprising a processor connected to the sensor of the sensor assembly.
20. A device according to Claim 19, further comprising an alarm connected to the processor.
21. A device according to Claim 20, wherein the alarm comprises an audible alarm.
22. A device according to Claim 20, wherein the alarm comprises a visual alarm.
23. A device according to Claim 20, wherein the processor is programmed to activate the alarm upon receiving the threshold signal from the sensor.
24. A device according to Claim 20, wherein the processor is programmed to activate the alarm upon receiving the threshold signal from the sensor for more than a predetermined period.
25. A device according to Claim 20, wherein the processor is programmed to activate the alarm upon receiving the threshold signal from the sensor for less than a predetermined period.
26. A device according to Claim 19, wherein the sensor provides an analog signal and the processor include an analog-to-digital converter for converting the analog single of the sensor into a digital signal.
27. A device according to Claim 19, wherein the processor is programmed to provide a signal indicative of an undesired flow condition upon receiving the threshold signal from the sensor.
28. A device according to Claim 19, wherein the processor is programmed to provide a signal indicative of an occluded flow condition upon receiving the threshold signal from the sensor for more than a predetermined period.
29. A device according to Claim 19, wherein the processor is programmed to provide a signal indicative of a low flow condition upon receiving the threshold signal from the sensor for less than a predetermined period.
30. A device according to Claim 19, wherein the processor is programmed to receive the threshold signal from the sensor when the device is primed.
31. A device according to Claim 1, wherein the flow path includes a reservoir containing a therapeutic fluid.
32. A device according to Claim 31, wherein the therapeutic fluid is insulin.
33. A device according to Claim 31, further comprising a fill port connected to the reservoir.
34. A device according to Claim 31, wherein the reservoir is pressurized.
35. A device according to Claim 1, wherein the exit port assembly includes a transcutaneous patient access tool.
36. A device according to Claim 35, wherein the transcutaneous patient access tool comprises a needle.
37. A device according to Claim 1, wherein a combined volume of the exit port assembly and the flow path is fixed and predetermined.
38. A device according to Claim 1, wherein possible expansion of a combined volume of the exit port assembly and the flow path is relatively small compared with the volume of the sensor chamber.
39. A device according to Claim 1, further comprising:
a dispenser for causing fluid through the flow path to the exit port assembly;
a local processor connected to the dispenser and programmed to cause fluid flow to the exit port assembly based upon flow instructions;
a wireless receiver connected to the local processor for receiving flow instructions from a separate, remote control device and delivering the flow instructions to the local processor; and a housing containing the flow path, the exit port assembly, the dispenser, the local processor, and the wireless receiver, wherein the housing is free of user input components for providing flow instructions to the local processor.
a dispenser for causing fluid through the flow path to the exit port assembly;
a local processor connected to the dispenser and programmed to cause fluid flow to the exit port assembly based upon flow instructions;
a wireless receiver connected to the local processor for receiving flow instructions from a separate, remote control device and delivering the flow instructions to the local processor; and a housing containing the flow path, the exit port assembly, the dispenser, the local processor, and the wireless receiver, wherein the housing is free of user input components for providing flow instructions to the local processor.
40. A system including a fluid delivery device according to Claim 39, and further comprising a remote control device separate from the fluid delivery device and including:
a remote processor;
user interface components connected to the remote processor for allowing a user to provide flow instructions to the remote processor; and a transmitter connected to the remote processor for transmitting the flow instructions to the receiver of the fluid delivery device.
a remote processor;
user interface components connected to the remote processor for allowing a user to provide flow instructions to the remote processor; and a transmitter connected to the remote processor for transmitting the flow instructions to the receiver of the fluid delivery device.
41. A device according to Claim 1, further comprising:
a dispenser for causing fluid through the flow path to the exit port assembly;
a local processor connected to the dispenser and programmed to cause fluid flow to the exit port assembly based upon flow instructions, and further programmed to provide flow information;
a wireless transmitter connected to the local processor for transmitting the flow information from the local processor to a separate, remote control device; and a housing containing the flow path, the exit port assembly, the dispenser, the local processor, and the wireless transmitter, wherein the housing is free of user output components for providing the flow information from the local processor to a user.
a dispenser for causing fluid through the flow path to the exit port assembly;
a local processor connected to the dispenser and programmed to cause fluid flow to the exit port assembly based upon flow instructions, and further programmed to provide flow information;
a wireless transmitter connected to the local processor for transmitting the flow information from the local processor to a separate, remote control device; and a housing containing the flow path, the exit port assembly, the dispenser, the local processor, and the wireless transmitter, wherein the housing is free of user output components for providing the flow information from the local processor to a user.
42. A system including a fluid delivery device according to Claim 41 and further comprising a remote control device separate from the fluid delivery device and including:
a remote processor;
user output components connected to the remote processor for allowing a user to receive flow information; and a receiver connected to the remote processor for receiving the flow information from the transmitter of the fluid delivery device.
a remote processor;
user output components connected to the remote processor for allowing a user to receive flow information; and a receiver connected to the remote processor for receiving the flow information from the transmitter of the fluid delivery device.
43. A system according to Claim 42, wherein the remote control device includes an alarm connected to the remote processor.
44. A device according to Claim 1, wherein the sensor assembly includes multiple sensor chambers positioned against the second surface of the diaphragm.
45. A device according to Claim 44, wherein the sensor assembly includes at least one of the sensors in each chamber.
46. A device according to Claim 44, wherein each of the sensor chambers of the sensor assembly has a predetermined volume.
47. A device according to Claim 1, wherein the sensor assembly includes a second diaphragm positioned against the flow path.
48. A device according to Claim 47, wherein the sensor assembly includes a second chamber assembly positioned against the second diaphragm.
49. A device according to Claim 48, wherein the sensor assembly includes a second sensor arranged to provide a threshold signal when the second diaphragm expands into the second chamber.
50. A device according to Claim 1, wherein the sensor comprises a path way extending through the sensor chamber, and an optical transmitter and an optical receiver positioned at opposite ends of the path way.
51. A device for delivering fluid to a patient, comprising:
A) a flow path extending from the exit port assembly;
B) a flow condition sensor assembly including, a resilient diaphragm having opposing first and second surfaces, with the first surface positioned against the flow path, a chamber wall positioned adjacent the second surface of the diaphragm and defining a sensor chamber adjacent the second surface of the diaphragm, and at least one sensor arranged to provide a threshold signal when the second surface of the diaphragm expands into the chamber by a predetermined amount;
and C) a processor connected to the sensor and programmed to provide a signal indicative of an undesired flow condition upon receiving the threshold signal from the sensor for more than a predetermined maximum period or for less than a predetermined minimum period.
A) a flow path extending from the exit port assembly;
B) a flow condition sensor assembly including, a resilient diaphragm having opposing first and second surfaces, with the first surface positioned against the flow path, a chamber wall positioned adjacent the second surface of the diaphragm and defining a sensor chamber adjacent the second surface of the diaphragm, and at least one sensor arranged to provide a threshold signal when the second surface of the diaphragm expands into the chamber by a predetermined amount;
and C) a processor connected to the sensor and programmed to provide a signal indicative of an undesired flow condition upon receiving the threshold signal from the sensor for more than a predetermined maximum period or for less than a predetermined minimum period.
52. A device according to Claim 51, further comprising an alarm connected to the processor and adapted to be activated upon the processor providing a signal indicative of an undesired flow condition.
53. A device according to Claim 52, wherein the alarm comprises an audible alarm.
54. A device according to Claim 52, wherein the alarm comprises a visual alarm.
55. A device according to Claim 51, wherein the sensor provides an analog signal and the processor include an analog-to-digital converter for converting the analog single of the sensor into a digital signal.
56. A device according to Claim 51, wherein the flow path includes a reservoir and the flow condition sensor assembly is positioned at an end of the reservoir.
57. A device according to Claim 51, wherein the flow path includes a reservoir and a passageway providing fluid communication between the reservoir and an exit port assembly, and the flow condition sensor assembly is positioned against the passageway.
58. A device according to Claim 51, wherein the sensor comprises a switch positioned within the chamber such that the second surface of the diaphragm closes the switch upon expanding into the chamber by the predetermined amount.
59. A device according to Claim 51, wherein the sensor is responsive to one of contact, pressure, light, magnetic, strain, and density.
60. A device according to Claim 51, wherein the sensor is positioned on a portion of the chamber wall furthest from the flow path and the enclosed chamber has a predetermined volume.
61. A device according to Claim 51, wherein the sensor comprises a circuit having a lead positioned on the second surface of the diaphragm and a lead positioned on the chamber wall such that the leads come together and close the circuit when the second surface of the diaphragm expands into the chamber by the predetermined amount.
62. A device according to Claim 51, wherein the sensor comprises a circuit having leads positioned on the chamber wall and a conductive layer positioned on the second surface of the diaphragm such that the conductive layer contacts the leads to close the circuit when the second surface of the diaphragm expands into the chamber in response to the predetermined fluid flow condition.
63. A device according to Claim 51, wherein the flow condition sensor assembly further comprises at least two laminated layers and the diaphragm is positioned between two of the layers.
64. A device according to Claim 63, wherein the at least two laminated layers comprise:
a first layer;
a second layer received against the first layer, the second and the first layers including at least one groove defining a passageway of the flow path, the second layer including an opening in fluid communication with the passageway, and wherein the resilient diaphragm is received on the second layer covering the opening; and a third layer received over the diaphragm on the second layer, the third layer including the chamber wall defining the chamber over the diaphragm and in alignment with the opening of the second layer.
a first layer;
a second layer received against the first layer, the second and the first layers including at least one groove defining a passageway of the flow path, the second layer including an opening in fluid communication with the passageway, and wherein the resilient diaphragm is received on the second layer covering the opening; and a third layer received over the diaphragm on the second layer, the third layer including the chamber wall defining the chamber over the diaphragm and in alignment with the opening of the second layer.
65. A device according to Claim 64, wherein one of the second and the third layers defines a recess receiving the diaphragm, and wherein the recess has a depth about equal to a thickness of the diaphragm such that the diaphragm is secured in a substantially fluid-tight manner between the second and the third layers.
66. A device according to Claim 65, wherein a length and a width of the recess are greater than a length and a width of the diaphragm.
67. A device according to Claim 51, wherein the diaphragm comprises a thin, flat piece of flexible and resilient material.
68. A device according to Claim 51, wherein the sensor chamber has a predetermined volume.
69. A device according to Claim 51, wherein the flow path includes a reservoir containing a therapeutic fluid.
70. A device according to Claim 69, wherein the therapeutic fluid is insulin.
71. A device according to Claim 69, wherein the reservoir is pressurized.
72. A device according to Claim 51, wherein the flow path includes an exit port assembly includes a transcutaneous patient access tool.
73. A device according to Claim 72, wherein the transcutaneous patient access tool comprises a needle.
74. A device according to Claim 51, wherein a combined volume of the flow path is substantially fixed and predetermined.
75. A device according to Claim 51, further comprising:
a dispenser for causing fluid to flow through the flow path;
a local processor connected to the dispenser and programmed to cause fluid flow based upon flow instructions;
a wireless receiver connected to the local processor for receiving flow instructions from a separate, remote control device and delivering the flow instructions to the local processor; and a housing containing the flow path, the dispenser, the local processor, and the wireless receiver, wherein the housing is free of user input components for providing flow instructions to the local processor.
a dispenser for causing fluid to flow through the flow path;
a local processor connected to the dispenser and programmed to cause fluid flow based upon flow instructions;
a wireless receiver connected to the local processor for receiving flow instructions from a separate, remote control device and delivering the flow instructions to the local processor; and a housing containing the flow path, the dispenser, the local processor, and the wireless receiver, wherein the housing is free of user input components for providing flow instructions to the local processor.
76. A system including a fluid delivery device according to Claim 75, and further comprising a remote control device separate from the fluid delivery device and including:
a remote processor;
user interface components connected to the remote processor for allowing a user to provide flow instructions to the remote processor; and a transmitter connected to the remote processor for transmitting the flow instructions to the receiver of the fluid delivery device.
a remote processor;
user interface components connected to the remote processor for allowing a user to provide flow instructions to the remote processor; and a transmitter connected to the remote processor for transmitting the flow instructions to the receiver of the fluid delivery device.
77. A device according to Claim 51, further comprising:
a dispenser for causing fluid to flow through the flow path;
a local processor connected to the dispenser and programmed to cause fluid flow through the flow path based upon flow instructions, and further programmed to provide flow information;
a wireless transmitter connected to the local processor for transmitting the flow information from the local processor to a separate, remote control device; and a housing containing the flow path, the dispenser, the local processor, and the wireless transmitter, wherein the housing is free of user output components for providing the flow information from the local processor to a user.
a dispenser for causing fluid to flow through the flow path;
a local processor connected to the dispenser and programmed to cause fluid flow through the flow path based upon flow instructions, and further programmed to provide flow information;
a wireless transmitter connected to the local processor for transmitting the flow information from the local processor to a separate, remote control device; and a housing containing the flow path, the dispenser, the local processor, and the wireless transmitter, wherein the housing is free of user output components for providing the flow information from the local processor to a user.
78. A system including a fluid delivery device according to Claim 77 and further comprising a remote control device separate from the fluid delivery device and including:
a remote processor;
user output components connected to the remote processor for allowing a user to receive flow information; and a receiver connected to the remote processor for receiving the flow information from the transmitter of the fluid delivery device.
a remote processor;
user output components connected to the remote processor for allowing a user to receive flow information; and a receiver connected to the remote processor for receiving the flow information from the transmitter of the fluid delivery device.
79. A device according to Claim 51, wherein the sensor assembly includes multiple sensor chambers positioned against the second surface of the diaphragm.
80. A device according to Claim 79, wherein the sensor assembly includes at least one of the sensors in each chamber.
81. A device according to Claim 79, wherein each of the sensor chambers of the sensor assembly has a predetermined volume.
82. A device according to Claim 51, wherein the sensor assembly includes a second diaphragm positioned against the flow path.
83. A device according to Claim 82, wherein the sensor assembly includes a second chamber assembly positioned against the second diaphragm.
84. A device according to Claim 83, wherein the sensor assembly includes a second sensor arranged to provide a threshold signal when the second diaphragm expands into the second chamber.
85. A device according to Claim 51, wherein the sensor comprises a path way extending through the sensor chamber, and an optical transmitter and an optical receiver positioned at opposite ends of the path way.
86. A device according to Claim 30, wherein the processor is programmed to stop operation upon receiving the threshold signal from the sensor.
87. A device according to Claim 30, wherein the processor is programmed to stop operation upon receiving the threshold signal from the sensor for more than a predetermined period.
88. A device according to Claim 30, wherein the processor is programmed to stop operation upon receiving the threshold signal from the sensor for less than a predetermined period.
89. A method for determining a fluid flow condition in a flow path, comprising:
positioning a first side of a resilient diaphragm against the flow path;
positioning a chamber wall adjacent a second surface of the diaphragm, the chamber wall defining a sensor chamber adjacent the second surface of the diaphragm;
providing a threshold signal when the second surface of the diaphragm expands into the chamber by a predetermined amount;
timing the duration of the threshold signal; and providing a signal indicative of a predetermined flow condition if the duration of the threshold signal is greater than a predetermined maximum period or less than a predetermined minimum period.
positioning a first side of a resilient diaphragm against the flow path;
positioning a chamber wall adjacent a second surface of the diaphragm, the chamber wall defining a sensor chamber adjacent the second surface of the diaphragm;
providing a threshold signal when the second surface of the diaphragm expands into the chamber by a predetermined amount;
timing the duration of the threshold signal; and providing a signal indicative of a predetermined flow condition if the duration of the threshold signal is greater than a predetermined maximum period or less than a predetermined minimum period.
90. A method according to claim 89, further comprising activating an alarm upon providing a signal indicative of a predetermined flow condition.
91. A method according to claim 89, further comprising providing the sensor chamber with a predetermined volume.
92. A method according to claim 89, further comprising providing the sensor chamber with a predetermined volume and providing a threshold signal when the second surface of the diaphragm contacts the chamber wall.
93. A method according to claim 89, further comprising providing the flow path with a substantially fixed and predetermined volume.
94. A method according to claim 89, wherein the predetermined fluid flow condition comprises one of an occlusion in the flow path, and an inadequate flow of fluid in the flow path.
95. A method according to claim 89, further comprising:
closing the flow path;
causing a volume of fluid at least equal to a volume of the sensor chamber to flow into the fluid path; and providing a signal indicative of an occlusion test failure if the duration of the threshold signal is less than the predetermined maximum period.
closing the flow path;
causing a volume of fluid at least equal to a volume of the sensor chamber to flow into the fluid path; and providing a signal indicative of an occlusion test failure if the duration of the threshold signal is less than the predetermined maximum period.
96. A method according to claim 95, further comprising positioning a second diaphragm against the flow path.
97. A method according to claim 89, further comprising:
providing pulsitile flow of fluid within the flow path; and monitoring the threshold signals between pulses of fluid.
providing pulsitile flow of fluid within the flow path; and monitoring the threshold signals between pulses of fluid.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/087,507 | 2002-03-01 | ||
US10/087,507 US6692457B2 (en) | 2002-03-01 | 2002-03-01 | Flow condition sensor assembly for patient infusion device |
PCT/US2003/003731 WO2003074121A1 (en) | 2002-03-01 | 2003-02-06 | Flow condition sensor for infusion device |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2475679A1 true CA2475679A1 (en) | 2003-09-12 |
Family
ID=27787547
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002475679A Abandoned CA2475679A1 (en) | 2002-03-01 | 2003-02-06 | Flow condition sensor for infusion device |
Country Status (7)
Country | Link |
---|---|
US (2) | US6692457B2 (en) |
EP (1) | EP1480711B1 (en) |
JP (1) | JP2006503600A (en) |
CN (1) | CN100448498C (en) |
AU (1) | AU2003210912A1 (en) |
CA (1) | CA2475679A1 (en) |
WO (1) | WO2003074121A1 (en) |
Families Citing this family (297)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6669669B2 (en) * | 2001-10-12 | 2003-12-30 | Insulet Corporation | Laminated patient infusion device |
JP2004521667A (en) * | 2000-09-08 | 2004-07-22 | インシュレット コーポレイション | Device, system and method for patient infusion |
US20040260233A1 (en) * | 2000-09-08 | 2004-12-23 | Garibotto John T. | Data collection assembly for patient infusion system |
AU2002239709B2 (en) * | 2000-12-21 | 2007-02-15 | Insulet Corporation | Medical apparatus remote control and method |
CN1556716A (en) * | 2001-02-22 | 2004-12-22 | ���Ͽع�����˾ | Modular infusion device and method |
WO2002078765A2 (en) * | 2001-04-02 | 2002-10-10 | The Hook Research Foundation | Programmable flexible-tube flow regulator and use methods |
DK1390089T3 (en) * | 2001-05-18 | 2007-05-29 | Deka Products Lp | Liquid pump infusion set |
US8034026B2 (en) * | 2001-05-18 | 2011-10-11 | Deka Products Limited Partnership | Infusion pump assembly |
US20030055380A1 (en) * | 2001-09-19 | 2003-03-20 | Flaherty J. Christopher | Plunger for patient infusion device |
DE10151471A1 (en) * | 2001-10-18 | 2003-05-15 | Disetronic Licensing Ag | Injection device with energy storage |
US20040078028A1 (en) * | 2001-11-09 | 2004-04-22 | Flaherty J. Christopher | Plunger assembly for patient infusion device |
US6830558B2 (en) * | 2002-03-01 | 2004-12-14 | Insulet Corporation | Flow condition sensor assembly for patient infusion device |
US7544179B2 (en) | 2002-04-11 | 2009-06-09 | Deka Products Limited Partnership | System and method for delivering a target volume of fluid |
US20050238507A1 (en) * | 2002-04-23 | 2005-10-27 | Insulet Corporation | Fluid delivery device |
US20040153032A1 (en) * | 2002-04-23 | 2004-08-05 | Garribotto John T. | Dispenser for patient infusion device |
US7018360B2 (en) * | 2002-07-16 | 2006-03-28 | Insulet Corporation | Flow restriction system and method for patient infusion device |
EP1545656A1 (en) | 2002-07-24 | 2005-06-29 | M 2 Medical A/S | An infusion pump system, an infusion pump unit and an infusion pump |
US20050160858A1 (en) * | 2002-07-24 | 2005-07-28 | M 2 Medical A/S | Shape memory alloy actuator |
US7144384B2 (en) * | 2002-09-30 | 2006-12-05 | Insulet Corporation | Dispenser components and methods for patient infusion device |
US7399401B2 (en) * | 2002-10-09 | 2008-07-15 | Abbott Diabetes Care, Inc. | Methods for use in assessing a flow condition of a fluid |
EP2322798A1 (en) | 2002-10-09 | 2011-05-18 | Abbott Diabetes Care Inc. | Device and method for delivering medical fluids using a shape memory alloy |
US7993108B2 (en) | 2002-10-09 | 2011-08-09 | Abbott Diabetes Care Inc. | Variable volume, shape memory actuated insulin dispensing pump |
US7727181B2 (en) * | 2002-10-09 | 2010-06-01 | Abbott Diabetes Care Inc. | Fluid delivery device with autocalibration |
EP1560616B1 (en) | 2002-11-05 | 2018-01-24 | Bigfoot Biomedical, Inc. | A disposable wearable insulin dispensing device, a combination of such a device and a programming controller |
CN1732027A (en) * | 2002-12-23 | 2006-02-08 | M2医药有限公司 | Flexible piston rod |
AU2003287926A1 (en) | 2002-12-23 | 2004-07-14 | M2 Medical A/S | A disposable, wearable insulin dispensing device, a combination of such a device and a programming controller and a method of controlling the operation of such a device |
CA2520880A1 (en) * | 2003-04-18 | 2004-11-04 | Insulet Corporation | User interface for infusion pump remote controller and method of using the same |
US20050182366A1 (en) * | 2003-04-18 | 2005-08-18 | Insulet Corporation | Method For Visual Output Verification |
AU2004232858B2 (en) | 2003-04-23 | 2009-07-09 | Mannkind Corporation | Hydraulically actuated pump for long duration medicament administration |
US7679407B2 (en) * | 2003-04-28 | 2010-03-16 | Abbott Diabetes Care Inc. | Method and apparatus for providing peak detection circuitry for data communication systems |
US20040220551A1 (en) * | 2003-04-30 | 2004-11-04 | Flaherty J. Christopher | Low profile components for patient infusion device |
US20060074381A1 (en) * | 2003-04-30 | 2006-04-06 | Luis Malave | Medical device initialization method & system |
WO2004098684A2 (en) * | 2003-05-08 | 2004-11-18 | Novo Nordisk A/S | Skin mountable injection device with a detachable needle insertion actuation |
EP1624914B1 (en) * | 2003-05-08 | 2008-04-16 | Novo Nordisk A/S | Internal needle inserter |
EP1475113A1 (en) * | 2003-05-08 | 2004-11-10 | Novo Nordisk A/S | External needle inserter |
US8460243B2 (en) * | 2003-06-10 | 2013-06-11 | Abbott Diabetes Care Inc. | Glucose measuring module and insulin pump combination |
US8071028B2 (en) * | 2003-06-12 | 2011-12-06 | Abbott Diabetes Care Inc. | Method and apparatus for providing power management in data communication systems |
US7722536B2 (en) * | 2003-07-15 | 2010-05-25 | Abbott Diabetes Care Inc. | Glucose measuring device integrated into a holster for a personal area network device |
EP1502613A1 (en) * | 2003-08-01 | 2005-02-02 | Novo Nordisk A/S | Needle device with retraction means |
US20190357827A1 (en) | 2003-08-01 | 2019-11-28 | Dexcom, Inc. | Analyte sensor |
US20050065760A1 (en) * | 2003-09-23 | 2005-03-24 | Robert Murtfeldt | Method for advising patients concerning doses of insulin |
US7066029B2 (en) | 2003-09-25 | 2006-06-27 | Deka Products Limited Partnership | System and method for improved volume measurement |
US9138537B2 (en) * | 2003-10-02 | 2015-09-22 | Medtronic, Inc. | Determining catheter status |
US8323244B2 (en) * | 2007-03-30 | 2012-12-04 | Medtronic, Inc. | Catheter malfunction determinations using physiologic pressure |
US9033920B2 (en) * | 2003-10-02 | 2015-05-19 | Medtronic, Inc. | Determining catheter status |
US7320676B2 (en) * | 2003-10-02 | 2008-01-22 | Medtronic, Inc. | Pressure sensing in implantable medical devices |
KR20060099520A (en) * | 2003-10-21 | 2006-09-19 | 노보 노르디스크 에이/에스 | Medical skin mountable device |
US8532730B2 (en) | 2006-10-04 | 2013-09-10 | Dexcom, Inc. | Analyte sensor |
US7753879B2 (en) | 2004-01-29 | 2010-07-13 | M2 Group Holdings, Inc. | Disposable medicine dispensing device |
EP1732626A1 (en) * | 2004-03-30 | 2006-12-20 | Novo Nordisk A/S | Actuator system comprising lever mechanism |
WO2005094919A1 (en) * | 2004-03-30 | 2005-10-13 | Novo Nordisk A/S | Actuator system comprising detection means |
WO2005107419A2 (en) * | 2004-05-04 | 2005-11-17 | E-Z-Em, Inc. | Method and system for implementing a graphical user interface for a multi-fluid injection device |
WO2005119524A2 (en) | 2004-06-04 | 2005-12-15 | Therasense, Inc. | Diabetes care host-client architecture and data management system |
US9089636B2 (en) * | 2004-07-02 | 2015-07-28 | Valeritas, Inc. | Methods and devices for delivering GLP-1 and uses thereof |
US20090012472A1 (en) * | 2004-09-22 | 2009-01-08 | Novo Nordisk A/S | Medical Device with Cannula Inserter |
US20080215006A1 (en) * | 2004-09-22 | 2008-09-04 | Novo Nordisk A/S | Medical Device with Transcutaneous Cannula Device |
US20090048563A1 (en) * | 2004-12-06 | 2009-02-19 | Novo Nordisk A/S | Ventilated Skin Mountable Device |
CN101107028B (en) | 2005-01-24 | 2013-04-10 | 诺和诺德公司 | Transcutaneous device assembly |
US20060178633A1 (en) * | 2005-02-03 | 2006-08-10 | Insulet Corporation | Chassis for fluid delivery device |
US7545272B2 (en) | 2005-02-08 | 2009-06-09 | Therasense, Inc. | RF tag on test strips, test strip vials and boxes |
CN101180093B (en) * | 2005-03-21 | 2012-07-18 | 雅培糖尿病护理公司 | Method and system for providing integrated medication infusion and analyte monitoring system |
EP1877115A1 (en) * | 2005-04-06 | 2008-01-16 | M 2 Medical A/S | An actuator |
US7905868B2 (en) * | 2006-08-23 | 2011-03-15 | Medtronic Minimed, Inc. | Infusion medium delivery device and method with drive device for driving plunger in reservoir |
US9233203B2 (en) | 2005-05-06 | 2016-01-12 | Medtronic Minimed, Inc. | Medical needles for damping motion |
US8512288B2 (en) * | 2006-08-23 | 2013-08-20 | Medtronic Minimed, Inc. | Infusion medium delivery device and method with drive device for driving plunger in reservoir |
US20080097291A1 (en) * | 2006-08-23 | 2008-04-24 | Hanson Ian B | Infusion pumps and methods and delivery devices and methods with same |
US8277415B2 (en) * | 2006-08-23 | 2012-10-02 | Medtronic Minimed, Inc. | Infusion medium delivery device and method with drive device for driving plunger in reservoir |
US8840586B2 (en) | 2006-08-23 | 2014-09-23 | Medtronic Minimed, Inc. | Systems and methods allowing for reservoir filling and infusion medium delivery |
US8137314B2 (en) * | 2006-08-23 | 2012-03-20 | Medtronic Minimed, Inc. | Infusion medium delivery device and method with compressible or curved reservoir or conduit |
EP1898975A2 (en) * | 2005-05-13 | 2008-03-19 | Novo Nordisk A/S | Medical device adapted to detect disengagement of a transcutaneous device |
US7768408B2 (en) | 2005-05-17 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and system for providing data management in data monitoring system |
US7552240B2 (en) * | 2005-05-23 | 2009-06-23 | International Business Machines Corporation | Method for user space operations for direct I/O between an application instance and an I/O adapter |
US7620437B2 (en) | 2005-06-03 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and apparatus for providing rechargeable power in data monitoring and management systems |
WO2007035658A2 (en) * | 2005-09-19 | 2007-03-29 | Lifescan, Inc. | Infusion pumps with a position detector |
WO2007035666A2 (en) * | 2005-09-19 | 2007-03-29 | Lifescan, Inc. | Electrokinetic infusion pump system |
US20070066940A1 (en) * | 2005-09-19 | 2007-03-22 | Lifescan, Inc. | Systems and Methods for Detecting a Partition Position in an Infusion Pump |
US8105279B2 (en) | 2005-09-26 | 2012-01-31 | M2 Group Holdings, Inc. | Dispensing fluid from an infusion pump system |
US8057436B2 (en) | 2005-09-26 | 2011-11-15 | Asante Solutions, Inc. | Dispensing fluid from an infusion pump system |
US8551046B2 (en) | 2006-09-18 | 2013-10-08 | Asante Solutions, Inc. | Dispensing fluid from an infusion pump system |
US8409142B2 (en) | 2005-09-26 | 2013-04-02 | Asante Solutions, Inc. | Operating an infusion pump system |
US7534226B2 (en) * | 2005-09-26 | 2009-05-19 | M2 Group Holdings, Inc. | Dispensing fluid from an infusion pump system |
US7794427B2 (en) * | 2005-09-26 | 2010-09-14 | Asante Solutions, Inc. | Operating an infusion pump system |
US7756561B2 (en) | 2005-09-30 | 2010-07-13 | Abbott Diabetes Care Inc. | Method and apparatus for providing rechargeable power in data monitoring and management systems |
US20070080223A1 (en) * | 2005-10-07 | 2007-04-12 | Sherwood Services Ag | Remote monitoring of medical device |
US7583190B2 (en) | 2005-10-31 | 2009-09-01 | Abbott Diabetes Care Inc. | Method and apparatus for providing data communication in data monitoring and management systems |
ATE439155T1 (en) * | 2005-11-08 | 2009-08-15 | M2 Medical As | INFUSION PUMP SYSTEM |
EP1955240B8 (en) | 2005-11-08 | 2016-03-30 | Bigfoot Biomedical, Inc. | Method for manual and autonomous control of an infusion pump |
US7942867B2 (en) | 2005-11-09 | 2011-05-17 | The Invention Science Fund I, Llc | Remotely controlled substance delivery device |
US20070106275A1 (en) | 2005-11-09 | 2007-05-10 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Reaction device controlled by RF control signal |
US8992511B2 (en) | 2005-11-09 | 2015-03-31 | The Invention Science Fund I, Llc | Acoustically controlled substance delivery device |
US9067047B2 (en) * | 2005-11-09 | 2015-06-30 | The Invention Science Fund I, Llc | Injectable controlled release fluid delivery system |
US8273071B2 (en) | 2006-01-18 | 2012-09-25 | The Invention Science Fund I, Llc | Remote controller for substance delivery system |
US8936590B2 (en) | 2005-11-09 | 2015-01-20 | The Invention Science Fund I, Llc | Acoustically controlled reaction device |
US8273075B2 (en) * | 2005-12-13 | 2012-09-25 | The Invention Science Fund I, Llc | Osmotic pump with remotely controlled osmotic flow rate |
US8083710B2 (en) * | 2006-03-09 | 2011-12-27 | The Invention Science Fund I, Llc | Acoustically controlled substance delivery device |
US8344966B2 (en) * | 2006-01-31 | 2013-01-01 | Abbott Diabetes Care Inc. | Method and system for providing a fault tolerant display unit in an electronic device |
CN109621078B (en) | 2006-02-09 | 2022-05-27 | 德卡产品有限公司 | System for controlling a wearable medical device |
US11497846B2 (en) | 2006-02-09 | 2022-11-15 | Deka Products Limited Partnership | Patch-sized fluid delivery systems and methods |
US11478623B2 (en) | 2006-02-09 | 2022-10-25 | Deka Products Limited Partnership | Infusion pump assembly |
US11364335B2 (en) | 2006-02-09 | 2022-06-21 | Deka Products Limited Partnership | Apparatus, system and method for fluid delivery |
US7981034B2 (en) | 2006-02-28 | 2011-07-19 | Abbott Diabetes Care Inc. | Smart messages and alerts for an infusion delivery and management system |
US20080140057A1 (en) * | 2006-03-09 | 2008-06-12 | Searete Llc, A Limited Liability Corporation Of State Of The Delaware | Injectable controlled release fluid delivery system |
EP1997233B1 (en) * | 2006-03-13 | 2014-03-05 | Novo Nordisk A/S | Secure pairing of electronic devices using dual means of communication |
WO2007104756A1 (en) * | 2006-03-13 | 2007-09-20 | Novo Nordisk A/S | Medical system comprising dual purpose communication means |
AU2007233231B2 (en) | 2006-03-30 | 2011-02-24 | Mannkind Corporation | Multi-cartridge fluid delivery device |
US20070233051A1 (en) * | 2006-03-31 | 2007-10-04 | David Hohl | Drug delivery systems and methods |
EP2010250A2 (en) * | 2006-04-06 | 2009-01-07 | Medtronic, Inc. | Systems and methods of identifying catheter malfunctions using pressure sensing |
EP2724736B1 (en) | 2006-04-14 | 2022-06-08 | DEKA Products Limited Partnership | Pod pump cassette |
US10537671B2 (en) | 2006-04-14 | 2020-01-21 | Deka Products Limited Partnership | Automated control mechanisms in a hemodialysis apparatus |
US20140199193A1 (en) | 2007-02-27 | 2014-07-17 | Deka Products Limited Partnership | Blood treatment systems and methods |
WO2007122207A1 (en) * | 2006-04-26 | 2007-11-01 | Novo Nordisk A/S | Skin-mountable device in packaging comprising coated seal member |
JP2009539444A (en) | 2006-06-06 | 2009-11-19 | ノボ・ノルデイスク・エー/エス | An assembly comprising a device attachable to the skin and a package of the device |
US20080004601A1 (en) * | 2006-06-28 | 2008-01-03 | Abbott Diabetes Care, Inc. | Analyte Monitoring and Therapy Management System and Methods Therefor |
US20090171269A1 (en) * | 2006-06-29 | 2009-07-02 | Abbott Diabetes Care, Inc. | Infusion Device and Methods Therefor |
US9119582B2 (en) | 2006-06-30 | 2015-09-01 | Abbott Diabetes Care, Inc. | Integrated analyte sensor and infusion device and methods therefor |
US8206296B2 (en) | 2006-08-07 | 2012-06-26 | Abbott Diabetes Care Inc. | Method and system for providing integrated analyte monitoring and infusion system therapy management |
US8932216B2 (en) * | 2006-08-07 | 2015-01-13 | Abbott Diabetes Care Inc. | Method and system for providing data management in integrated analyte monitoring and infusion system |
US7828764B2 (en) * | 2006-08-23 | 2010-11-09 | Medtronic Minimed, Inc. | Systems and methods allowing for reservoir filling and infusion medium delivery |
US7811262B2 (en) * | 2006-08-23 | 2010-10-12 | Medtronic Minimed, Inc. | Systems and methods allowing for reservoir filling and infusion medium delivery |
US7794434B2 (en) * | 2006-08-23 | 2010-09-14 | Medtronic Minimed, Inc. | Systems and methods allowing for reservoir filling and infusion medium delivery |
US7789857B2 (en) * | 2006-08-23 | 2010-09-07 | Medtronic Minimed, Inc. | Infusion medium delivery system, device and method with needle inserter and needle inserter device and method |
US20080051765A1 (en) * | 2006-08-23 | 2008-02-28 | Medtronic Minimed, Inc. | Systems and methods allowing for reservoir filling and infusion medium delivery |
US8202267B2 (en) * | 2006-10-10 | 2012-06-19 | Medsolve Technologies, Inc. | Method and apparatus for infusing liquid to a body |
US8579853B2 (en) | 2006-10-31 | 2013-11-12 | Abbott Diabetes Care Inc. | Infusion devices and methods |
US7654127B2 (en) * | 2006-12-21 | 2010-02-02 | Lifescan, Inc. | Malfunction detection in infusion pumps |
US20080161754A1 (en) * | 2006-12-29 | 2008-07-03 | Medsolve Technologies, Inc. | Method and apparatus for infusing liquid to a body |
US8491184B2 (en) | 2007-02-27 | 2013-07-23 | Deka Products Limited Partnership | Sensor apparatus systems, devices and methods |
US8042563B2 (en) | 2007-02-27 | 2011-10-25 | Deka Products Limited Partnership | Cassette system integrated apparatus |
US8409441B2 (en) | 2007-02-27 | 2013-04-02 | Deka Products Limited Partnership | Blood treatment systems and methods |
US20080253911A1 (en) | 2007-02-27 | 2008-10-16 | Deka Products Limited Partnership | Pumping Cassette |
US10463774B2 (en) | 2007-02-27 | 2019-11-05 | Deka Products Limited Partnership | Control systems and methods for blood or fluid handling medical devices |
EP4309691A3 (en) | 2007-02-27 | 2024-04-24 | DEKA Products Limited Partnership | Hemodialysis systems |
US9028691B2 (en) | 2007-02-27 | 2015-05-12 | Deka Products Limited Partnership | Blood circuit assembly for a hemodialysis system |
EP2114492A1 (en) * | 2007-03-06 | 2009-11-11 | Novo Nordisk A/S | Pump assembly comprising actuator system |
US9044537B2 (en) | 2007-03-30 | 2015-06-02 | Medtronic, Inc. | Devices and methods for detecting catheter complications |
US7963954B2 (en) | 2007-04-30 | 2011-06-21 | Medtronic Minimed, Inc. | Automated filling systems and methods |
US8434528B2 (en) * | 2007-04-30 | 2013-05-07 | Medtronic Minimed, Inc. | Systems and methods for reservoir filling |
US8613725B2 (en) | 2007-04-30 | 2013-12-24 | Medtronic Minimed, Inc. | Reservoir systems and methods |
WO2008136845A2 (en) | 2007-04-30 | 2008-11-13 | Medtronic Minimed, Inc. | Reservoir filling, bubble management, and infusion medium delivery systems and methods with same |
US8597243B2 (en) | 2007-04-30 | 2013-12-03 | Medtronic Minimed, Inc. | Systems and methods allowing for reservoir air bubble management |
US8323250B2 (en) * | 2007-04-30 | 2012-12-04 | Medtronic Minimed, Inc. | Adhesive patch systems and methods |
US7959715B2 (en) | 2007-04-30 | 2011-06-14 | Medtronic Minimed, Inc. | Systems and methods allowing for reservoir air bubble management |
US7833196B2 (en) * | 2007-05-21 | 2010-11-16 | Asante Solutions, Inc. | Illumination instrument for an infusion pump |
US7794426B2 (en) | 2007-05-21 | 2010-09-14 | Asante Solutions, Inc. | Infusion pump system with contamination-resistant features |
US7981102B2 (en) * | 2007-05-21 | 2011-07-19 | Asante Solutions, Inc. | Removable controller for an infusion pump |
US7892199B2 (en) * | 2007-05-21 | 2011-02-22 | Asante Solutions, Inc. | Occlusion sensing for an infusion pump |
US8641618B2 (en) * | 2007-06-27 | 2014-02-04 | Abbott Diabetes Care Inc. | Method and structure for securing a monitoring device element |
US8085151B2 (en) * | 2007-06-28 | 2011-12-27 | Abbott Diabetes Care Inc. | Signal converting cradle for medical condition monitoring and management system |
EP2022519A1 (en) * | 2007-08-10 | 2009-02-11 | F. Hoffmann-La Roche AG | Device for detecting a pressure change in the liquid path of a micro dosing apparatus |
US7717903B2 (en) | 2007-09-06 | 2010-05-18 | M2 Group Holdings, Inc. | Operating an infusion pump system |
US7828528B2 (en) * | 2007-09-06 | 2010-11-09 | Asante Solutions, Inc. | Occlusion sensing system for infusion pumps |
US8287514B2 (en) | 2007-09-07 | 2012-10-16 | Asante Solutions, Inc. | Power management techniques for an infusion pump system |
US8032226B2 (en) | 2007-09-07 | 2011-10-04 | Asante Solutions, Inc. | User profile backup system for an infusion pump device |
US7879026B2 (en) | 2007-09-07 | 2011-02-01 | Asante Solutions, Inc. | Controlled adjustment of medicine dispensation from an infusion pump device |
US7935076B2 (en) | 2007-09-07 | 2011-05-03 | Asante Solutions, Inc. | Activity sensing techniques for an infusion pump system |
DE102007049446A1 (en) | 2007-10-16 | 2009-04-23 | Cequr Aps | Catheter introducer |
EP2209500B1 (en) * | 2007-10-31 | 2015-07-22 | Novo Nordisk A/S | Non-porous material as sterilization barrier |
US7875022B2 (en) | 2007-12-12 | 2011-01-25 | Asante Solutions, Inc. | Portable infusion pump and media player |
US20090157003A1 (en) * | 2007-12-14 | 2009-06-18 | Jones Daniel W | Method And Apparatus For Occlusion Prevention And Remediation |
US8414563B2 (en) * | 2007-12-31 | 2013-04-09 | Deka Products Limited Partnership | Pump assembly with switch |
US9456955B2 (en) | 2007-12-31 | 2016-10-04 | Deka Products Limited Partnership | Apparatus, system and method for fluid delivery |
US8881774B2 (en) | 2007-12-31 | 2014-11-11 | Deka Research & Development Corp. | Apparatus, system and method for fluid delivery |
US10188787B2 (en) | 2007-12-31 | 2019-01-29 | Deka Products Limited Partnership | Apparatus, system and method for fluid delivery |
US8900188B2 (en) | 2007-12-31 | 2014-12-02 | Deka Products Limited Partnership | Split ring resonator antenna adapted for use in wirelessly controlled medical device |
MX2010007324A (en) | 2007-12-31 | 2010-09-30 | Deka Products Lp | Infusion pump assembly. |
US10080704B2 (en) | 2007-12-31 | 2018-09-25 | Deka Products Limited Partnership | Apparatus, system and method for fluid delivery |
US10201647B2 (en) | 2008-01-23 | 2019-02-12 | Deka Products Limited Partnership | Medical treatment system and methods using a plurality of fluid lines |
US9028440B2 (en) | 2008-01-23 | 2015-05-12 | Deka Products Limited Partnership | Fluid flow occluder and methods of use for medical treatment systems |
US8986253B2 (en) | 2008-01-25 | 2015-03-24 | Tandem Diabetes Care, Inc. | Two chamber pumps and related methods |
US8708961B2 (en) * | 2008-01-28 | 2014-04-29 | Medsolve Technologies, Inc. | Apparatus for infusing liquid to a body |
US8234126B1 (en) | 2008-02-12 | 2012-07-31 | Asante Solutions, Inc. | Distribution of infusion pumps |
US20090270844A1 (en) * | 2008-04-24 | 2009-10-29 | Medtronic, Inc. | Flow sensor controlled infusion device |
US7959598B2 (en) | 2008-08-20 | 2011-06-14 | Asante Solutions, Inc. | Infusion pump systems and methods |
CA2738389C (en) | 2008-09-15 | 2017-01-17 | Deka Products Limited Partnership | Systems and methods for fluid delivery |
US8408421B2 (en) | 2008-09-16 | 2013-04-02 | Tandem Diabetes Care, Inc. | Flow regulating stopcocks and related methods |
AU2009293019A1 (en) | 2008-09-19 | 2010-03-25 | Tandem Diabetes Care Inc. | Solute concentration measurement device and related methods |
EP2349405B1 (en) * | 2008-09-22 | 2019-11-20 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Device for determining at least one flow parameter |
US8066672B2 (en) | 2008-10-10 | 2011-11-29 | Deka Products Limited Partnership | Infusion pump assembly with a backup power supply |
US8708376B2 (en) * | 2008-10-10 | 2014-04-29 | Deka Products Limited Partnership | Medium connector |
US9180245B2 (en) | 2008-10-10 | 2015-11-10 | Deka Products Limited Partnership | System and method for administering an infusible fluid |
US8016789B2 (en) * | 2008-10-10 | 2011-09-13 | Deka Products Limited Partnership | Pump assembly with a removable cover assembly |
US8223028B2 (en) | 2008-10-10 | 2012-07-17 | Deka Products Limited Partnership | Occlusion detection system and method |
US8267892B2 (en) | 2008-10-10 | 2012-09-18 | Deka Products Limited Partnership | Multi-language / multi-processor infusion pump assembly |
US8262616B2 (en) * | 2008-10-10 | 2012-09-11 | Deka Products Limited Partnership | Infusion pump assembly |
US9375529B2 (en) | 2009-09-02 | 2016-06-28 | Becton, Dickinson And Company | Extended use medical device |
CA3149758A1 (en) | 2009-01-12 | 2010-07-15 | Becton, Dickinson And Company | Infusion set and/or patch pump having at least one of an in-dwelling rigid catheter with flexible features and/or a flexible catheter attachment |
US8560082B2 (en) | 2009-01-30 | 2013-10-15 | Abbott Diabetes Care Inc. | Computerized determination of insulin pump therapy parameters using real time and retrospective data processing |
US20100217233A1 (en) * | 2009-02-20 | 2010-08-26 | Ranft Elizabeth A | Method and device to anesthetize an area |
US9250106B2 (en) | 2009-02-27 | 2016-02-02 | Tandem Diabetes Care, Inc. | Methods and devices for determination of flow reservoir volume |
EP2401587A2 (en) | 2009-02-27 | 2012-01-04 | Tandem Diabetes Care, Inc. | Methods and devices for determination of flow reservoir volume |
WO2010129375A1 (en) | 2009-04-28 | 2010-11-11 | Abbott Diabetes Care Inc. | Closed loop blood glucose control algorithm analysis |
EP2453948B1 (en) | 2009-07-15 | 2015-02-18 | DEKA Products Limited Partnership | Apparatus, systems and methods for an infusion pump assembly |
CH701492A1 (en) | 2009-07-20 | 2011-01-31 | Tecpharma Licensing Ag | Delivery device with a means for detecting pressure changes. |
US8939928B2 (en) * | 2009-07-23 | 2015-01-27 | Becton, Dickinson And Company | Medical device having capacitive coupling communication and energy harvesting |
ES2888427T3 (en) | 2009-07-23 | 2022-01-04 | Abbott Diabetes Care Inc | Real-time management of data related to the physiological control of glucose levels |
CA2769030C (en) | 2009-07-30 | 2016-05-10 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
US8547239B2 (en) | 2009-08-18 | 2013-10-01 | Cequr Sa | Methods for detecting failure states in a medicine delivery device |
US8672873B2 (en) | 2009-08-18 | 2014-03-18 | Cequr Sa | Medicine delivery device having detachable pressure sensing unit |
US10092691B2 (en) | 2009-09-02 | 2018-10-09 | Becton, Dickinson And Company | Flexible and conformal patch pump |
US8008080B2 (en) | 2009-09-23 | 2011-08-30 | Ecolab Usa Inc. | Valve analytical system |
WO2011091265A1 (en) | 2010-01-22 | 2011-07-28 | Deka Products Limited Partnership | Method and system for shape-memory alloy wire control |
US8096186B2 (en) * | 2010-03-24 | 2012-01-17 | Carefusion 303, Inc. | Systems and methods for measuring fluid pressure within a disposable IV set connected to a fluid supply pump |
JP5101659B2 (en) * | 2010-05-25 | 2012-12-19 | 株式会社東芝 | Blood pressure sensor |
USD669165S1 (en) | 2010-05-27 | 2012-10-16 | Asante Solutions, Inc. | Infusion pump |
EA024052B1 (en) | 2010-06-07 | 2016-08-31 | Эмджен Инк. | Drug delivery device |
EP2591385B1 (en) | 2010-07-07 | 2017-10-11 | DEKA Products Limited Partnership | Medical treatment system and methods using a plurality of fluid lines |
US9498573B2 (en) | 2010-09-24 | 2016-11-22 | Perqflo, Llc | Infusion pumps |
US9216249B2 (en) | 2010-09-24 | 2015-12-22 | Perqflo, Llc | Infusion pumps |
US8915879B2 (en) | 2010-09-24 | 2014-12-23 | Perqflo, Llc | Infusion pumps |
US9308320B2 (en) | 2010-09-24 | 2016-04-12 | Perqflo, Llc | Infusion pumps |
US9211378B2 (en) | 2010-10-22 | 2015-12-15 | Cequr Sa | Methods and systems for dosing a medicament |
WO2012059209A1 (en) * | 2010-11-01 | 2012-05-10 | Roche Diagnostics Gmbh | Fluid dispensing device with a flow detector |
US8905972B2 (en) | 2010-11-20 | 2014-12-09 | Perqflo, Llc | Infusion pumps |
US8795230B2 (en) | 2010-11-30 | 2014-08-05 | Becton, Dickinson And Company | Adjustable height needle infusion device |
US9950109B2 (en) | 2010-11-30 | 2018-04-24 | Becton, Dickinson And Company | Slide-activated angled inserter and cantilevered ballistic insertion for intradermal drug infusion |
US8814831B2 (en) | 2010-11-30 | 2014-08-26 | Becton, Dickinson And Company | Ballistic microneedle infusion device |
US8852152B2 (en) | 2011-02-09 | 2014-10-07 | Asante Solutions, Inc. | Infusion pump systems and methods |
US10136845B2 (en) | 2011-02-28 | 2018-11-27 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
US8454581B2 (en) | 2011-03-16 | 2013-06-04 | Asante Solutions, Inc. | Infusion pump systems and methods |
JP6141827B2 (en) | 2011-04-15 | 2017-06-07 | デックスコム・インコーポレーテッド | Method of operating a system for measuring an analyte and sensor system configured to implement the method |
SG10201604167XA (en) | 2011-05-24 | 2016-07-28 | Deka Products Lp | Blood treatment systems and methods |
US9999717B2 (en) | 2011-05-24 | 2018-06-19 | Deka Products Limited Partnership | Systems and methods for detecting vascular access disconnection |
CA3078889C (en) | 2011-05-24 | 2022-08-30 | Deka Products Limited Partnership | Hemodialysis system |
US8585657B2 (en) | 2011-06-21 | 2013-11-19 | Asante Solutions, Inc. | Dispensing fluid from an infusion pump system |
US8808230B2 (en) * | 2011-09-07 | 2014-08-19 | Asante Solutions, Inc. | Occlusion detection for an infusion pump system |
US9623173B2 (en) | 2012-03-05 | 2017-04-18 | Becton, Dickinson And Company | Wireless communication for on-body medical devices |
US11524151B2 (en) | 2012-03-07 | 2022-12-13 | Deka Products Limited Partnership | Apparatus, system and method for fluid delivery |
US9180242B2 (en) | 2012-05-17 | 2015-11-10 | Tandem Diabetes Care, Inc. | Methods and devices for multiple fluid transfer |
US9238100B2 (en) | 2012-06-07 | 2016-01-19 | Tandem Diabetes Care, Inc. | Device and method for training users of ambulatory medical devices |
CN104602719B (en) * | 2012-06-28 | 2017-07-21 | 凯希特许有限公司 | Wound connection gasket with RFID and integrated strain gauge pressure sensor |
US8454557B1 (en) | 2012-07-19 | 2013-06-04 | Asante Solutions, Inc. | Infusion pump system and method |
US8454562B1 (en) | 2012-07-20 | 2013-06-04 | Asante Solutions, Inc. | Infusion pump system and method |
US20140052009A1 (en) * | 2012-08-15 | 2014-02-20 | Acist Medical Systems, Inc. | Monitoring blood pressure in a medical injection system |
CN102813974A (en) * | 2012-09-04 | 2012-12-12 | 南昌贝欧特医疗设备有限公司 | Infusion alarming device |
US9132034B2 (en) * | 2012-10-01 | 2015-09-15 | Alcon Research, Ltd. | Valve position sensor |
CA2887504C (en) * | 2012-10-12 | 2021-05-25 | Becton, Dickinson And Company | System and method for detecting occlusions in a medication infusion system using pulsewise pressure signals |
US9427523B2 (en) | 2012-12-10 | 2016-08-30 | Bigfoot Biomedical, Inc. | Infusion pump system and method |
US20140276536A1 (en) | 2013-03-14 | 2014-09-18 | Asante Solutions, Inc. | Infusion Pump System and Methods |
US9446186B2 (en) | 2013-03-01 | 2016-09-20 | Bigfoot Biomedical, Inc. | Operating an infusion pump system |
US9173998B2 (en) | 2013-03-14 | 2015-11-03 | Tandem Diabetes Care, Inc. | System and method for detecting occlusions in an infusion pump |
JP2014200617A (en) * | 2013-04-10 | 2014-10-27 | セイコーエプソン株式会社 | Fluid injection device and clogging detection method |
US9446187B2 (en) | 2013-06-03 | 2016-09-20 | Bigfoot Biomedical, Inc. | Infusion pump system and method |
US9457141B2 (en) | 2013-06-03 | 2016-10-04 | Bigfoot Biomedical, Inc. | Infusion pump system and method |
EP4309699A3 (en) | 2013-07-03 | 2024-04-24 | DEKA Products Limited Partnership | Apparatus and system for fluid delivery |
US9561324B2 (en) | 2013-07-19 | 2017-02-07 | Bigfoot Biomedical, Inc. | Infusion pump system and method |
KR102235689B1 (en) | 2013-07-30 | 2021-04-02 | 삼성전자주식회사 | Liquid occlusion detection apparatus and method |
US10569015B2 (en) | 2013-12-02 | 2020-02-25 | Bigfoot Biomedical, Inc. | Infusion pump system and method |
US9737656B2 (en) | 2013-12-26 | 2017-08-22 | Tandem Diabetes Care, Inc. | Integration of infusion pump with remote electronic device |
US10004845B2 (en) | 2014-04-18 | 2018-06-26 | Becton, Dickinson And Company | Split piston metering pump |
US9629901B2 (en) | 2014-07-01 | 2017-04-25 | Bigfoot Biomedical, Inc. | Glucagon administration system and methods |
US9416775B2 (en) | 2014-07-02 | 2016-08-16 | Becton, Dickinson And Company | Internal cam metering pump |
JP5908033B2 (en) * | 2014-07-14 | 2016-04-26 | ミネベア株式会社 | Occlusion detection device and infusion device |
US10137246B2 (en) | 2014-08-06 | 2018-11-27 | Bigfoot Biomedical, Inc. | Infusion pump assembly and method |
US9919096B2 (en) | 2014-08-26 | 2018-03-20 | Bigfoot Biomedical, Inc. | Infusion pump system and method |
US11464899B2 (en) | 2014-08-28 | 2022-10-11 | Becton, Dickinson And Company | Wireless communication for on-body medical devices |
MX357797B (en) | 2014-09-19 | 2018-07-25 | Flow Control LLC | Automatic fill control technique. |
US10159786B2 (en) | 2014-09-30 | 2018-12-25 | Perqflo, Llc | Hybrid ambulatory infusion pumps |
EP3650060B1 (en) | 2015-02-18 | 2021-09-29 | Medtronic Minimed, Inc. | Ambulatory infusion pumps and reservoir assemblies for use with same |
US10589016B2 (en) * | 2015-04-15 | 2020-03-17 | Gambro Lundia Ab | Treatment system with infusion apparatus pressure priming |
US9878097B2 (en) | 2015-04-29 | 2018-01-30 | Bigfoot Biomedical, Inc. | Operating an infusion pump system |
WO2017087888A1 (en) | 2015-11-18 | 2017-05-26 | President And Fellows Of Harvard College | Systems and methods for monitoring, managing, and treating asthma and anaphylaxis |
WO2017091624A1 (en) | 2015-11-24 | 2017-06-01 | Insulet Corporation | Wearable automated medication delivery system |
JP2019509770A (en) | 2016-01-05 | 2019-04-11 | ビッグフット バイオメディカル インコーポレイテッドBigfoot Biomedical, Inc. | A working multimodal drug delivery system |
US10449294B1 (en) | 2016-01-05 | 2019-10-22 | Bigfoot Biomedical, Inc. | Operating an infusion pump system |
CA3014280A1 (en) | 2016-02-12 | 2017-08-17 | Perqflo, Llc | Ambulatory infusion pumps and assemblies for use with same |
USD809134S1 (en) | 2016-03-10 | 2018-01-30 | Bigfoot Biomedical, Inc. | Infusion pump assembly |
US10172993B2 (en) * | 2016-04-14 | 2019-01-08 | Fresenius Medical Care Holdings, Inc. | Wave-based patient line blockage detection |
US10052441B2 (en) * | 2016-08-02 | 2018-08-21 | Becton, Dickinson And Company | System and method for measuring delivered dose |
CN110675949A (en) | 2016-09-27 | 2020-01-10 | 比格福特生物医药公司 | Drug injection and disease management systems, devices and methods |
WO2018096534A1 (en) | 2016-11-22 | 2018-05-31 | Sorrel Medical Ltd. | Apparatus for delivering a therapeutic substance |
USD836769S1 (en) | 2016-12-12 | 2018-12-25 | Bigfoot Biomedical, Inc. | Insulin delivery controller |
US11096624B2 (en) | 2016-12-12 | 2021-08-24 | Bigfoot Biomedical, Inc. | Alarms and alerts for medication delivery devices and systems |
USD839294S1 (en) | 2017-06-16 | 2019-01-29 | Bigfoot Biomedical, Inc. | Display screen with graphical user interface for closed-loop medication delivery |
WO2019014594A1 (en) | 2017-07-13 | 2019-01-17 | Desborough Lane | Multi-scale display of blood glucose information |
SG11202009360WA (en) | 2018-03-30 | 2020-10-29 | Deka Products Lp | Liquid pumping cassettes and associated pressure distribution manifold and related methods |
US11583633B2 (en) | 2018-04-03 | 2023-02-21 | Amgen Inc. | Systems and methods for delayed drug delivery |
CA3098372A1 (en) | 2018-04-24 | 2019-10-31 | Deka Products Limited Partnership | Apparatus and system for fluid delivery |
CA3051543A1 (en) | 2018-08-30 | 2020-02-29 | Becton, Dickinson And Company | Liquid medicament reservoir empty detection sensor and occlusion sensor for medicament delivery device |
EP3744368A1 (en) | 2018-10-05 | 2020-12-02 | Sorrel Medical Ltd. | Triggering sequence |
KR20210154199A (en) * | 2019-04-16 | 2021-12-20 | 인퓨젼 이노베이션즈 피티와이 엘티디 | sensor array |
JP2022541492A (en) | 2019-07-16 | 2022-09-26 | ベータ バイオニクス,インコーポレイテッド | blood sugar control system |
US20220189603A1 (en) * | 2020-12-07 | 2022-06-16 | Beta Bionics, Inc. | Medicament pumps and control systems for managing glucose control therapy data of a subject |
US11633537B1 (en) | 2021-02-19 | 2023-04-25 | Fresenius Kabi Deutschland Gmbh | Drug delivery assembly including a pre-filled cartridge |
US11406755B1 (en) | 2021-02-19 | 2022-08-09 | Fresenius Kabi Deutschland Gmbh | Sensing fluid flow irregularities in an on-body injector |
US11607505B1 (en) | 2021-02-19 | 2023-03-21 | Fresenius Kabi Deutschland Gmbh | Wearable injector with sterility sensors |
US11413394B1 (en) | 2021-02-19 | 2022-08-16 | Fresenius Kabi Deutschland Gmbh | Display for wearable drug delivery device |
US11426523B1 (en) | 2021-02-19 | 2022-08-30 | Fresenius Kabi Deutschland Gmbh | Drug delivery assembly including a removable cartridge |
US11344682B1 (en) | 2021-02-19 | 2022-05-31 | Fresenius Kabi Deutschland Gmbh | Drug supply cartridge with visual use indicator and delivery devices that use the same |
US11497847B1 (en) | 2021-02-19 | 2022-11-15 | Fresenius Kabi Deutschland Gmbh | Wearable injector with adhesive substrate |
US11504470B1 (en) | 2021-04-30 | 2022-11-22 | Fresenius Kabi Deutschland Gmbh | Deformable drug reservoir for wearable drug delivery device |
US11529459B1 (en) | 2021-04-30 | 2022-12-20 | Fresenius Kabi Deutschland Gmbh | Wearable injector with adhesive module |
US11419976B1 (en) | 2021-04-30 | 2022-08-23 | Fresenius Kabi Deutschland Gmbh | Wearable drug delivery device with pressurized fluid dispensing |
US11351300B1 (en) | 2021-04-30 | 2022-06-07 | Fresenius Kabl Deutschland GmbH | Drug dispensing system with replaceable drug supply cartridges |
US11717608B1 (en) | 2021-05-03 | 2023-08-08 | Fresenius Kabi Deutschland Gmbh | Drug delivery assembly including an adhesive pad |
US11484646B1 (en) | 2021-05-04 | 2022-11-01 | Fresenius Kabi Deutschland Gmbh | Sealing systems for a reservoir of an on-body injector |
CN116983504A (en) * | 2022-04-26 | 2023-11-03 | 深圳硅基传感科技有限公司 | Medical device and medical system for delivering fluids |
US20240009390A1 (en) * | 2022-07-07 | 2024-01-11 | Insulet Corporation | System and method for detecting occlusions in a fluid path |
Family Cites Families (164)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US315727A (en) * | 1885-04-14 | Odometer for vehicles | ||
US405524A (en) * | 1889-06-18 | Whip-socket | ||
US311735A (en) * | 1885-02-03 | Printing-press | ||
US303013A (en) * | 1884-08-05 | Pen-holder | ||
US5338157B1 (en) * | 1992-09-09 | 1999-11-02 | Sims Deltec Inc | Systems and methods for communicating with ambulat |
US5935099A (en) | 1992-09-09 | 1999-08-10 | Sims Deltec, Inc. | Drug pump systems and methods |
US3631847A (en) | 1966-03-04 | 1972-01-04 | James C Hobbs | Method and apparatus for injecting fluid into the vascular system |
US3812843A (en) | 1973-03-12 | 1974-05-28 | Lear Siegler Inc | Method and apparatus for injecting contrast media into the vascular system |
US3885662A (en) * | 1973-12-26 | 1975-05-27 | Ibm | Steerable follower selection mechanism |
FR2348709A1 (en) | 1976-04-23 | 1977-11-18 | Pistor Michel | MESOTHERAPIC TREATMENT PROCESS AND INJECTION DEVICE, FORMING AUTOMATIC MICRO-INJECTOR, INCLUDING APPLICATION |
US4067000A (en) | 1976-05-28 | 1978-01-03 | Rca Corporation | Remote control transmitter with an audible battery life indicator |
DE2738155A1 (en) | 1977-08-24 | 1979-03-08 | Stierlen Maquet Ag | REMOTE CONTROL ARRANGEMENT FOR A MEDICAL DEVICE |
DE2738406A1 (en) | 1977-08-25 | 1979-03-08 | Stierlen Maquet Ag | PROCEDURE AND REMOTE CONTROL ARRANGEMENT FOR REMOTE CONTROL OF A MEDICAL DEVICE |
US4151845A (en) | 1977-11-25 | 1979-05-01 | Miles Laboratories, Inc. | Blood glucose control apparatus |
US4193397A (en) * | 1977-12-01 | 1980-03-18 | Metal Bellows Corporation | Infusion apparatus and method |
US4559037A (en) | 1977-12-28 | 1985-12-17 | Siemens Aktiengesellschaft | Device for the pre-programmable infusion of liquids |
US4373527B1 (en) | 1979-04-27 | 1995-06-27 | Univ Johns Hopkins | Implantable programmable medication infusion system |
US4268150A (en) | 1980-01-28 | 1981-05-19 | Laurence Chen | Disposable camera with simplified film advance and indicator |
CA1169323A (en) | 1980-06-03 | 1984-06-19 | Anthony M. Albisser | Insulin infusion device |
AU546785B2 (en) | 1980-07-23 | 1985-09-19 | Commonwealth Of Australia, The | Open-loop controlled infusion of diabetics |
US4551143A (en) * | 1980-10-06 | 1985-11-05 | Johnson & Johnson Baby Products Company | Nonwoven fibrous product and method of making same |
US4559033A (en) | 1980-10-27 | 1985-12-17 | University Of Utah Research Foundation | Apparatus and methods for minimizing peritoneal injection catheter obstruction |
US4398542A (en) * | 1980-12-15 | 1983-08-16 | Ivac Corporation | Pressure diaphragm |
US4424720A (en) | 1980-12-15 | 1984-01-10 | Ivac Corporation | Mechanism for screw drive and syringe plunger engagement/disengagement |
US4364385A (en) | 1981-03-13 | 1982-12-21 | Lossef Steven V | Insulin delivery device |
JPS57163309A (en) * | 1981-04-01 | 1982-10-07 | Olympus Optical Co Ltd | Capsule apparatus for medical use |
JPS57211361A (en) | 1981-06-23 | 1982-12-25 | Terumo Corp | Liquid injecting apparatus |
US4529401A (en) | 1982-01-11 | 1985-07-16 | Cardiac Pacemakers, Inc. | Ambulatory infusion pump having programmable parameters |
US4435173A (en) | 1982-03-05 | 1984-03-06 | Delta Medical Industries | Variable rate syringe pump for insulin delivery |
US4498843A (en) | 1982-08-02 | 1985-02-12 | Schneider Philip H | Insulin infusion pump |
US4551134A (en) * | 1982-08-06 | 1985-11-05 | Nuvatec, Inc. | Intravenous set |
US4514732A (en) | 1982-08-23 | 1985-04-30 | General Electric Company | Technique for increasing battery life in remote control transmitters |
US4624661A (en) | 1982-11-16 | 1986-11-25 | Surgidev Corp. | Drug dispensing system |
DE3314664C2 (en) | 1983-04-22 | 1985-02-21 | B. Braun Melsungen Ag, 3508 Melsungen | Procedure for triggering a pre-alarm in a pressure infusion apparatus |
US4781693A (en) | 1983-09-02 | 1988-11-01 | Minntech Corporation | Insulin dispenser for peritoneal cavity |
EP0143895B1 (en) | 1983-09-07 | 1987-12-23 | Disetronic Ag | Portable infusion apparatus |
US4685903A (en) | 1984-01-06 | 1987-08-11 | Pacesetter Infusion, Ltd. | External infusion pump apparatus |
US4562751A (en) | 1984-01-06 | 1986-01-07 | Nason Clyde K | Solenoid drive apparatus for an external infusion pump |
US4678408A (en) | 1984-01-06 | 1987-07-07 | Pacesetter Infusion, Ltd. | Solenoid drive apparatus for an external infusion pump |
US4684368A (en) | 1984-06-01 | 1987-08-04 | Parker Hannifin Corporation | Inverted pump |
US4855746A (en) | 1984-07-30 | 1989-08-08 | Zenith Electronics Corporation | Multiple device remote control transmitter |
US4634427A (en) | 1984-09-04 | 1987-01-06 | American Hospital Supply Company | Implantable demand medication delivery assembly |
CA1254091A (en) | 1984-09-28 | 1989-05-16 | Vladimir Feingold | Implantable medication infusion system |
GB2176595A (en) * | 1985-06-05 | 1986-12-31 | Warner Lambert Co | Pressure sensing device |
US4755173A (en) | 1986-02-25 | 1988-07-05 | Pacesetter Infusion, Ltd. | Soft cannula subcutaneous injection set |
US4778451A (en) | 1986-03-04 | 1988-10-18 | Kamen Dean L | Flow control system using boyle's law |
US5349852A (en) | 1986-03-04 | 1994-09-27 | Deka Products Limited Partnership | Pump controller using acoustic spectral analysis |
AT384737B (en) | 1986-04-04 | 1987-12-28 | Thoma Dipl Ing Dr Techn Herwig | DEVICE FOR CONTINUOUSLY DELIVERING LIQUID MEDICINAL PRODUCTS |
USD306691S (en) | 1986-05-23 | 1990-03-20 | Fuji Photo Film Co., Ltd. | Disposable camera |
USD303013S (en) | 1986-06-19 | 1989-08-22 | Pacesetter Infusion, Ltd. | Female luer connector |
USD311735S (en) | 1986-06-30 | 1990-10-30 | Fuji Photo Film Co., Ltd. | Disposable camera |
USD315305S (en) | 1986-06-30 | 1991-03-12 | Fuji Photo Film Co., Ltd. | Package for a disposable camera |
CA1283827C (en) | 1986-12-18 | 1991-05-07 | Giorgio Cirelli | Appliance for injection of liquid formulations |
GB8701731D0 (en) * | 1987-01-27 | 1987-03-04 | Patcentre Benelux Nv Sa | Pumps |
US4734092A (en) | 1987-02-18 | 1988-03-29 | Ivac Corporation | Ambulatory drug delivery device |
DE3882202D1 (en) | 1987-05-18 | 1993-08-12 | Disetronic Ag | Infusionsgeraet. |
US4898579A (en) | 1987-06-26 | 1990-02-06 | Pump Controller Corporation | Infusion pump |
US4836752A (en) * | 1987-11-02 | 1989-06-06 | Fisher Scientific Company | Partial restriction detector |
US4801957A (en) | 1988-02-18 | 1989-01-31 | Eastman Kodak Company | Disposable single-use camera and accessory re-usable electronic flash unit |
US4898585A (en) | 1988-05-18 | 1990-02-06 | Baxter Healthcare Corporation | Implantable patient-activated fluid delivery device with bolus injection port |
US5062841A (en) | 1988-08-12 | 1991-11-05 | The Regents Of The University Of California | Implantable, self-regulating mechanochemical insulin pump |
US4882600A (en) | 1989-04-07 | 1989-11-21 | Eastman Kodak Company | Underwater disposable single-use camera |
US5205819A (en) | 1989-05-11 | 1993-04-27 | Bespak Plc | Pump apparatus for biomedical use |
US5129891A (en) | 1989-05-19 | 1992-07-14 | Strato Medical Corporation | Catheter attachment device |
US5411480A (en) | 1989-06-16 | 1995-05-02 | Science Incorporated | Fluid delivery apparatus |
US5045871A (en) | 1989-06-30 | 1991-09-03 | Reinholdson Mark R | Disposable camera |
US4973998A (en) | 1990-01-16 | 1990-11-27 | Eastman Kodak Company | Disposable single-use camera and accessory re-usable electronic flash unit |
US5109850A (en) | 1990-02-09 | 1992-05-05 | Massachusetts Institute Of Technology | Automatic blood monitoring for medication delivery method and apparatus |
US5318540A (en) | 1990-04-02 | 1994-06-07 | Pharmetrix Corporation | Controlled release infusion device |
US5492534A (en) | 1990-04-02 | 1996-02-20 | Pharmetrix Corporation | Controlled release portable pump |
US5007458A (en) | 1990-04-23 | 1991-04-16 | Parker Hannifin Corporation | Poppet diaphragm valve |
JPH0451966A (en) * | 1990-06-19 | 1992-02-20 | Toichi Ishikawa | Medical fluid continuous injector |
US5176662A (en) | 1990-08-23 | 1993-01-05 | Minimed Technologies, Ltd. | Subcutaneous injection set with improved cannula mounting arrangement |
US5242406A (en) | 1990-10-19 | 1993-09-07 | Sil Medics Ltd. | Liquid delivery device particularly useful for delivering drugs |
TW279133B (en) | 1990-12-13 | 1996-06-21 | Elan Med Tech | |
US5245447A (en) * | 1991-05-20 | 1993-09-14 | Xerox Corporation | Indexing mechanism for compact scanner |
US5213483A (en) | 1991-06-19 | 1993-05-25 | Strato Medical Corporation | Peristaltic infusion pump with removable cassette and mechanically keyed tube set |
US5207645A (en) * | 1991-06-25 | 1993-05-04 | Medication Delivery Devices | Infusion pump, treatment fluid bag therefor, and method for the use thereof |
US5239326A (en) | 1991-08-07 | 1993-08-24 | Kabushiki Kaisha Senshukai | Film-loaded disposable camera |
DE4129271C1 (en) | 1991-09-03 | 1992-09-17 | Fresenius Ag, 6380 Bad Homburg, De | |
US5244463A (en) | 1991-12-06 | 1993-09-14 | Block Medical, Inc. | Programmable infusion pump |
DE4200595C2 (en) | 1992-01-13 | 1994-10-13 | Michail Efune | Assembly for the infusion set for an insulin pump |
US5911716A (en) | 1992-01-24 | 1999-06-15 | I-Flow Corporation | Platen pump |
US5267956A (en) * | 1992-02-05 | 1993-12-07 | Alcon Surgical, Inc. | Surgical cassette |
US5346476A (en) * | 1992-04-29 | 1994-09-13 | Edward E. Elson | Fluid delivery system |
IE930532A1 (en) | 1993-07-19 | 1995-01-25 | Elan Med Tech | Liquid material dispenser and valve |
US5342298A (en) * | 1992-07-31 | 1994-08-30 | Advanced Cardiovascular Systems, Inc. | Automated fluid pressure control system |
US5254096A (en) | 1992-09-23 | 1993-10-19 | Becton, Dickinson And Company | Syringe pump with graphical display or error conditions |
US5232439A (en) | 1992-11-02 | 1993-08-03 | Infusion Technologies Corporation | Method for pumping fluid from a flexible, variable geometry reservoir |
US5342313A (en) | 1992-11-02 | 1994-08-30 | Infusion Technologies Corporation | Fluid pump for a flexible, variable geometry reservoir |
US5433710A (en) | 1993-03-16 | 1995-07-18 | Minimed, Inc. | Medication infusion pump with fluoropolymer valve seat |
DE4310808C2 (en) | 1993-04-02 | 1995-06-22 | Boehringer Mannheim Gmbh | Liquid dosing system |
US5257980A (en) | 1993-04-05 | 1993-11-02 | Minimed Technologies, Ltd. | Subcutaneous injection set with crimp-free soft cannula |
US5868678A (en) * | 1993-06-30 | 1999-02-09 | Medex, Inc. | Two-part medical pressure transducer with diaphragm stand-offs |
EP0722540B1 (en) | 1993-10-04 | 1998-12-23 | Research International, Inc. | Micromachined fluid flow regulators |
US5563584A (en) * | 1993-11-15 | 1996-10-08 | The Johns Hopkins University | Liquid level sensing and monitoring system for medical fluid infusion systems |
US5997501A (en) | 1993-11-18 | 1999-12-07 | Elan Corporation, Plc | Intradermal drug delivery device |
JP3259267B2 (en) | 1993-12-28 | 2002-02-25 | ニプロ株式会社 | Chemical injection device |
US5643213A (en) | 1994-03-09 | 1997-07-01 | I-Flow Corporation | Elastomeric syringe actuation device |
US5630710A (en) | 1994-03-09 | 1997-05-20 | Baxter International Inc. | Ambulatory infusion pump |
DE4415896A1 (en) | 1994-05-05 | 1995-11-09 | Boehringer Mannheim Gmbh | Analysis system for monitoring the concentration of an analyte in the blood of a patient |
US5576781A (en) | 1994-05-16 | 1996-11-19 | Deleeuw; Paul | Disposable camera |
US5452033A (en) | 1994-06-06 | 1995-09-19 | Eastman Kodak Company | Single use photographic film package and camera |
US5582593A (en) | 1994-07-21 | 1996-12-10 | Hultman; Barry W. | Ambulatory medication delivery system |
JPH0858897A (en) | 1994-08-12 | 1996-03-05 | Japan Storage Battery Co Ltd | Fluid supply device |
US5505709A (en) | 1994-09-15 | 1996-04-09 | Minimed, Inc., A Delaware Corporation | Mated infusion pump and syringe |
US5545152A (en) | 1994-10-28 | 1996-08-13 | Minimed Inc. | Quick-connect coupling for a medication infusion system |
CA2159052C (en) | 1994-10-28 | 2007-03-06 | Rainer Alex | Injection device |
DE69508730T2 (en) * | 1994-12-28 | 1999-10-21 | Agfa Gevaert Nv | Image element and method for producing lithographic printing plates by the silver salt diffusion transfer method |
US5637095A (en) | 1995-01-13 | 1997-06-10 | Minimed Inc. | Medication infusion pump with flexible drive plunger |
US5665070A (en) | 1995-01-19 | 1997-09-09 | I-Flow Corporation | Infusion pump with magnetic bag compression |
JPH08219913A (en) * | 1995-02-10 | 1996-08-30 | Hosiden Corp | Fluid pressure sensor |
US5741228A (en) | 1995-02-17 | 1998-04-21 | Strato/Infusaid | Implantable access device |
US5647853A (en) | 1995-03-03 | 1997-07-15 | Minimed Inc. | Rapid response occlusion detector for a medication infusion pump |
US5575770A (en) | 1995-04-05 | 1996-11-19 | Therex Corporation | Implantable drug infusion system with safe bolus capability |
DE69637457T2 (en) | 1995-04-20 | 2008-10-02 | ACIST Medical Systems, Inc., Eden Prairie | Injector for X-ray contrast agent |
US5665065A (en) | 1995-05-26 | 1997-09-09 | Minimed Inc. | Medication infusion device with blood glucose data input |
US5702363A (en) | 1995-06-07 | 1997-12-30 | Flaherty; J. Christopher | Septumless implantable treatment material device |
US5695490A (en) | 1995-06-07 | 1997-12-09 | Strato/Infusaid, Inc. | Implantable treatment material device |
US5584813A (en) | 1995-06-07 | 1996-12-17 | Minimed Inc. | Subcutaneous injection set |
US5810015A (en) | 1995-09-01 | 1998-09-22 | Strato/Infusaid, Inc. | Power supply for implantable device |
IE77523B1 (en) | 1995-09-11 | 1997-12-17 | Elan Med Tech | Medicament delivery device |
DE69618405T2 (en) | 1995-09-18 | 2002-08-01 | Becton Dickinson Co | Needle protection with collapsing cover |
US5726751A (en) | 1995-09-27 | 1998-03-10 | University Of Washington | Silicon microchannel optical flow cytometer |
US5779676A (en) | 1995-10-11 | 1998-07-14 | Science Incorporated | Fluid delivery device with bolus injection site |
US5776103A (en) | 1995-10-11 | 1998-07-07 | Science Incorporated | Fluid delivery device with bolus injection site |
US5800405A (en) | 1995-12-01 | 1998-09-01 | I-Flow Corporation | Syringe actuation device |
US6206850B1 (en) * | 1996-03-14 | 2001-03-27 | Christine O'Neil | Patient controllable drug delivery system flow regulating means |
US5976109A (en) * | 1996-04-30 | 1999-11-02 | Medtronic, Inc. | Apparatus for drug infusion implanted within a living body |
US5785688A (en) | 1996-05-07 | 1998-07-28 | Ceramatec, Inc. | Fluid delivery apparatus and method |
US5726404A (en) | 1996-05-31 | 1998-03-10 | University Of Washington | Valveless liquid microswitch |
IL118689A (en) | 1996-06-20 | 2000-10-31 | Gadot Amir | Intravenous infusion apparatus |
US5755682A (en) | 1996-08-13 | 1998-05-26 | Heartstent Corporation | Method and apparatus for performing coronary artery bypass surgery |
US5748827A (en) | 1996-10-23 | 1998-05-05 | University Of Washington | Two-stage kinematic mount |
US5753820A (en) * | 1996-10-25 | 1998-05-19 | Arthur D. Little, Inc. | Fluid pressure sensing unit incorporating diaphragm deflection sensing array |
US5886647A (en) | 1996-12-20 | 1999-03-23 | Badger; Berkley C. | Apparatus and method for wireless, remote control of multiple devices |
US5851197A (en) | 1997-02-05 | 1998-12-22 | Minimed Inc. | Injector for a subcutaneous infusion set |
US5785681A (en) | 1997-02-25 | 1998-07-28 | Minimed Inc. | Flow rate controller for a medication infusion pump |
US5845218A (en) | 1997-02-28 | 1998-12-01 | Altschul; Randice-Lisa | Disposable wireless telephone and method |
US6061580A (en) | 1997-02-28 | 2000-05-09 | Randice-Lisa Altschul | Disposable wireless telephone and method for call-out only |
US5875393A (en) | 1997-02-28 | 1999-02-23 | Randice-Lisa Altschul | Disposable wireless telephone and method |
CH692240A5 (en) | 1997-03-26 | 2002-04-15 | Disetronic Licensing Ag | Catheter system for transdermal passage devices. |
US5957890A (en) | 1997-06-09 | 1999-09-28 | Minimed Inc. | Constant flow medication infusion pump |
US6071292A (en) | 1997-06-28 | 2000-06-06 | Transvascular, Inc. | Transluminal methods and devices for closing, forming attachments to, and/or forming anastomotic junctions in, luminal anatomical structures |
US5965848A (en) | 1997-07-22 | 1999-10-12 | Randice-Lisa Altschul | Disposable portable electronic devices and method of making |
US5858005A (en) | 1997-08-27 | 1999-01-12 | Science Incorporated | Subcutaneous infusion set with dynamic needle |
US6527744B1 (en) | 1997-08-27 | 2003-03-04 | Science Incorporated | Fluid delivery device with light activated energy source |
US5961492A (en) | 1997-08-27 | 1999-10-05 | Science Incorporated | Fluid delivery device with temperature controlled energy source |
US6019747A (en) | 1997-10-21 | 2000-02-01 | I-Flow Corporation | Spring-actuated infusion syringe |
US5983094A (en) | 1997-10-27 | 1999-11-09 | Randice-Lisa Altschul | Wireless telephone with credited airtime and method |
DE19920896A1 (en) | 1999-05-06 | 2000-11-09 | Phiscience Gmbh Entwicklung Vo | Portable unit for the supply of medicaments to a patient comprises a delivery unit connected to the patient by e.g. a catheter, and an operating unit which has wireless communication with the delivery unit |
US5897530A (en) | 1997-12-24 | 1999-04-27 | Baxter International Inc. | Enclosed ambulatory pump |
US5957895A (en) | 1998-02-20 | 1999-09-28 | Becton Dickinson And Company | Low-profile automatic injection device with self-emptying reservoir |
US5919167A (en) | 1998-04-08 | 1999-07-06 | Ferring Pharmaceuticals | Disposable micropump |
USD405524S (en) | 1998-05-01 | 1999-02-09 | Elan Medical Technologies Limited | Drug delivery device |
US5906597A (en) | 1998-06-09 | 1999-05-25 | I-Flow Corporation | Patient-controlled drug administration device |
US5993423A (en) | 1998-08-18 | 1999-11-30 | Choi; Soo Bong | Portable automatic syringe device and injection needle unit thereof |
US6375638B2 (en) * | 1999-02-12 | 2002-04-23 | Medtronic Minimed, Inc. | Incremental motion pump mechanisms powered by shape memory alloy wire or the like |
US6666665B1 (en) * | 1999-03-04 | 2003-12-23 | Baxter International Inc. | Fluid delivery mechanism having a plurality of plungers for compressing a metering chamber |
JP3260721B2 (en) * | 1999-04-02 | 2002-02-25 | 山形日本電気株式会社 | Diaphragm vacuum gauge |
US6152898A (en) | 1999-04-30 | 2000-11-28 | Medtronic, Inc. | Overfill protection systems for implantable drug delivery devices |
US6520936B1 (en) * | 1999-06-08 | 2003-02-18 | Medtronic Minimed, Inc. | Method and apparatus for infusing liquids using a chemical reaction in an implanted infusion device |
US6363609B1 (en) | 2000-10-20 | 2002-04-02 | Short Block Technologies, Inc. | Method and apparatus for aligning crankshaft sections |
CN1293069A (en) * | 2000-11-27 | 2001-05-02 | 李永慎 | Medical infusion device |
-
2002
- 2002-03-01 US US10/087,507 patent/US6692457B2/en not_active Expired - Fee Related
-
2003
- 2003-02-06 CN CNB038050374A patent/CN100448498C/en not_active Expired - Fee Related
- 2003-02-06 JP JP2003572631A patent/JP2006503600A/en active Pending
- 2003-02-06 AU AU2003210912A patent/AU2003210912A1/en not_active Abandoned
- 2003-02-06 EP EP03743667.2A patent/EP1480711B1/en not_active Expired - Lifetime
- 2003-02-06 WO PCT/US2003/003731 patent/WO2003074121A1/en active Application Filing
- 2003-02-06 CA CA002475679A patent/CA2475679A1/en not_active Abandoned
- 2003-10-08 US US10/681,688 patent/US7887505B2/en active Active - Reinstated
Also Published As
Publication number | Publication date |
---|---|
CN100448498C (en) | 2009-01-07 |
EP1480711A1 (en) | 2004-12-01 |
US20030167036A1 (en) | 2003-09-04 |
CN1638834A (en) | 2005-07-13 |
WO2003074121A1 (en) | 2003-09-12 |
EP1480711B1 (en) | 2015-04-15 |
JP2006503600A (en) | 2006-02-02 |
US20040127844A1 (en) | 2004-07-01 |
AU2003210912A1 (en) | 2003-09-16 |
US6692457B2 (en) | 2004-02-17 |
EP1480711A4 (en) | 2008-08-06 |
US7887505B2 (en) | 2011-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6692457B2 (en) | Flow condition sensor assembly for patient infusion device | |
US6830558B2 (en) | Flow condition sensor assembly for patient infusion device | |
US7018360B2 (en) | Flow restriction system and method for patient infusion device | |
US6669669B2 (en) | Laminated patient infusion device | |
EP1549382B1 (en) | Transcutaneous access tool for patient infusion device | |
US6656159B2 (en) | Dispenser for patient infusion device | |
EP1341569B1 (en) | Transcutaneous delivery means | |
EP1427471B1 (en) | Plunger for patient infusion device | |
US20080132842A1 (en) | Plunger assembly for patient infusion device | |
US20040153032A1 (en) | Dispenser for patient infusion device | |
AU2002331913A1 (en) | Laminated patient infusion device | |
AU2002331800A1 (en) | Plunger for patient infusion device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |
Effective date: 20121119 |